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Abstract 
GSK3β is a multipurpose serine-threonine kinase which plays a role in many signaling 
pathways. Abnormal Glycogen Synthase Kinase 3β (GSK3β) function has been implicated in 
many diverse disease states including mental illness. Its part in neurological disease stems from its 
abnormal activity within the WNT/β-catenin signaling pathway. One of the binding partners of 
GSK3β within the WNT pathway that is linked to psychiatric disease is Disrupted in Schizophrenia 
1 (DISC1). DISC1 has been suspected to play a role in individuals presenting with mental illness. 
Research in this area is lacking in the amount of information known about how GSK3β and DISC1 
interact together. In the presence of a WNT signal, DISC1 is thought to participate in the binding 
complex that inhibits GSK3β activity. This thesis aims to identify a potential binding site for a 
small fragment of the DISC1 protein. Studies were conducted using Surface Plasmon Resonance 
and kinetic enzyme assays. The ability to determine the location of DISC1 binding is essential to 
better understanding the mechanism behind DISC1’s ability to inhibit GSK3β. Most of the work 
is centered around the production of a His-tagged GSK3β eukaryotic construct using a bacterial 
overexpression system and its subsequent isolation utilizing a series of affinity and ion exchange 
liquid chromatography columns. This process was optimized to obtain GSK3β with a purity level 
of 80% to use in subsequent studies. Binding interaction studies using surface plasmon resonance 
technology were conducted to determine the suspected binding site of a short 44mer fragment of 
DISC1 on GSK3β. The binding interaction studies utilized competitive binding methods between 
the 44mer fragment and a small peptide fragment of the GSK3β binding protein FRAT 
(FRATtide). FRATtide is a peptide with a known binding location on GSK3β. The work developed 
a likely model representing how the DISC1 fragment binds GSK3β in the presence of FRATtide.   
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1.0 Introduction 
1.1 General Topic & Significance  
There exists a biological link between the way in which disease is experienced by an individual 
and the molecular functioning of the protein subunits within that individuals’ cells. For many 
disease states, including mental illness, the presentation of the disease is the result of one or more 
malfunctioning proteins at the cellular level. An example of this was noted in a large Scottish 
family where a specific chromosomal translocation resulted in a truncated protein responsible for 
members of the family who presented with schizophrenia, bipolar disorder or depression (Millar 
et al., 2000). Genes such as these, often interact with environmental factors to produce the 
manifestation of disease. Particularly in the case of mental illness, there is a substantial connection 
between mental health and the molecular functioning of neural progenitor cells. Neural progenitor 
cells are essentially neural stem cells produced in the subventricular zone and the olfactory bulb 
of the adult human brain (Piatti et al., 2013; Snyder et al., 1992; Temple, 1989). These neural 
progenitor cells can migrate throughout the brain and differentiate into necessary cell types 
(Magavi et al., 2000). Neural progenitor cells have been hypothesised to aid in the typical brain 
functioning, memory and in response to injury (Kim et al., 2012; Magavi et al., 2000). Irregularities 
within these neural stem cells may lead to the development or presentation of specific mental 
illness. These irregularities can occur in genes coding for enzymes or structural proteins which is 
why it becomes essential to understand the relationship between proteins at a molecular level. 
Gaining insight into the complexity and intricacies of protein-protein interactions is a critical 
fundamental building block to understanding disease states as a whole. This thesis focuses on the 
relationship between an enzyme, Glycogen Synthase Kinase 3β (GSK3β), and a scaffold-like 
protein, Disrupted in Schizophrenia 1 (DISC1), both of which have been implicated in psychiatric 
disease (Chen et al., 2015). Both proteins have been identified within neural stem cells and have 
been linked to the presentation of psychiatric disease states in animal models (Mao et al., 2009) 
 2 
Of specific interest within the scope of this thesis, is the role DISC1 plays in regulating GSK3b 
activity within the canonical Wingless/Integrated (WNT) signaling pathway   
1.2 GSK3b Structure and Function 
GSK3b is a serine/threonine kinase that has a broad spectrum of potential substrates and 
influences many different signalling pathways. Its structure consists of a typical kinase fold 
comprising of two main domains (Figure 1-1). The b strand domain resides from residues 25 to 
138 in the N terminal end of the protein (Dajani et al.; Haar et al., 2001). This b strand domain has  
Figure 1- 1: Protein structure of GSK3b.  
Enzyme active site (boxed) sandwiched between an N terminal - barrel domain and a C terminal α-helix domain 
by a functional hinge (salmon pink). ADP (light pink) and two Mg2+ molecules (raspberry) bound in the substrate 
binding groove. Short α helix in the Ν terminal domain (lime green) followed by the C loop (violet). A glycine-
rich loop (sky blue), activation loop (orange) and C loop (violet) all play a role in the active site. Tyr216 (lime 
green) is auto-phosphorylated for enzyme activity. Phosphorylated peptide Ser9 (bright pink) interacts with Arg96 
(purple sticks) in the region where phosphorylated Ser9 is predicted to bind for enzyme inhibition. The active site 
consisting of Asp181, Asp200, Lys85, and Glu97 (dark blue sticks) is required for substrate binding (PDB file 
4NM3).  
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seven antiparallel b strands where the 4th and 5th strand are separated by a short α helix (Dajani et 
al.; Haar et al., 2001) (Figure 1-1 Lime green helix). This helix is typical of the functionality of 
catalytic activity in kinases. The C terminal domain resides from residues 139 to 343 and is made 
up of α helices (Dajani et al.; Haar et al., 2001). The ATP binding site is at the interface of the two 
domains and is accompanied by a glycine-rich loop (Figure 1-1 sky blue) and a functional hinge 
(Haar et al., 2001) (Figure 1-1 salmon). The activation loop of the enzyme is located from residues 
200 to 226 and outlines the substrate binding groove (Figure 1-1 orange). The far ends of the N 
terminus (preceding Lys35) and C terminus (following Ser386) are disordered in nature and can 
be challenging to visualize within the crystal structure (Dajani et al.). The C loop (Figure 1-1 
violet) is involved in enzyme inhibition mechanism as it undergoes a conformational change when 
an inhibitor peptide is bound as a pseudo-substrate (Stamos et al., 2014). This C loop moves 
towards the C terminal lobe of the kinase and sits down on top of the inhibitory peptides in a 
clamp-like fashion (Stamos et al., 2014). GSK3b contains a short segment which acts as a nuclear 
localization signal (NLS) located in the N terminus (Residues 85-103) which is required for 
nuclear shuttling, but despite its presence, GSK3b remains primarily localized in the cytosol 
(Meares and Jope, 2007).  
GSK3b is a constitutively active Ser/Thr kinase which is unique in that phosphorylation acts 
to inhibit the enzyme instead of activating it. GSK3b is predominantly a Ser/Thr kinase but can 
phosphorylate its own Tyrosine residues in an autophosphorylation event (Tong et al., 2018). This 
autophosphorylation occurs via the aid of heat shock protein (Hsp90) at Tyr216 (Figure 1-1 bright 
green stick) during a transitory intermediate phase that occurs after translation and during protein 
folding (Lochhead et al., 2006). The autophosphorylation of Tyr216 is required for GSK3b activity 
as it allows for a conformational change which opens up the binding site for substrates (Cole et 
al., 2004; Hughes et al., 1993; Tong et al., 2018). This phosphorylation appears to be hidden or 
protected from dephosphorylation, and thus inhibition of GSK3b is not achieved through removal 
of this phosphate group (Lochhead et al., 2006). Instead, inhibition is achieved through 
phosphorylation of a separate amino acid residue, specifically Ser9 (Cross et al., 1995; Shaw et 
al., 1997) (Figure 1-1 Inhibitory Phosphorylated S9 bright pink). Ser9 is located in the disordered 
N terminus of the protein and as such is not easily viewed in crystal structures (Stamos et al., 
2014). This characteristic  leads many groups use versions of the construct that lack the end 
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terminal disordered region altogether. Stamos and colleagues (2014) successfully crystallized a 
full-length GSK3b construct which contained a phosphorylated Ser9 residue. The resulting 
structure showed the phosphorylated Ser9 bound to GSK3b near the active site while the remainder 
of the N terminal residues (residues 1-5 and 11-25) are mostly disordered and unable to be viewed 
clearly in the crystal structure (Figure 1-1). Stamos and colleges (2014) simultaneously conducted 
enzymatic studies of GSK3b activity in the presence of a phosphorylated Ser9 and demonstrated 
that Ser9-P was able to inhibit GSK3b. It is hypothesized that Ser9 bends around and interact with 
Arg96 (Frame et al., 2001) (Figure 1-1 purple stick) since it is located in the flexible N terminal 
region of the protein. Arg96 is the same residue within the binding site that would regularly interact 
with the primed phosphate on GSK3b substrates (Frame et al., 2001). The function of this 
phosphorylated Ser9 is to act as a physical obstruction against primed substrates for access to the 
active site (Beurel et al., 2015; Stamos et al., 2014). The active site for GSK3b involves the 
residues Asp181 (D181), Asp200 (D200), Lys85 (K85), and Glu97 (E97) (Dajani et al.) (Figure 
1-1 dark blue sticks). The priming phosphate region refers to GSK3b’s preference to phosphorylate 
substrates that have already been pre-phosphorylated at a Ser or Thr four residues in the C-terminal 
direction from GSK3b’s phosphorylation site (P+4) (Beurel et al., 2015). The specific sequence 
motif recognized in this phosphorylation event is S/T-X-X-X-S(P)/T(P). Some substrates contain 
multiple sequential motifs such that another enzyme phosphorylates the first S/T but once GSK3b 
recognizes the first S/T it acts as the pre-phosphorylated site for the next phosphorylation event 4 
additional residues in the N terminal direction (Beurel et al., 2015; Frame et al., 2001; Stamos et 
al., 2014).  
 GSK3b is highly conserved across plants, fungi, worms, flies, sea squirts and vertebrates 
(Woodgett JR, 1991) and ubiquitously expressed in all types of cells and tissues including the brain 
(Doble, 2003; Krishnankutty et al., 2017). GSK3b is involved in a diverse set of cell signaling 
pathways including those responsible for cell proliferation, cell architecture and neural 
development (Patel and Woodgett, 2017). As a result of being so diverse, it has been implicated in 
playing a role in the development of some cancers, diabetes, neurodegenerative and psychiatric 
disease (Krishnankutty et al., 2017). Its malfunction has also been implicated in neurological 
conditions including Alzheimer’s disease where it is predicted to influence hyperphosphorylation 
of the Tau protein, the subsequent detachment of microtubules and the phosphorylation of amyloid 
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precursors leading to aggregation of αβ plaques (Maqbool et al., 2016; Martin et al., 2018). 
Abnormal GSK3b function has been hypothesized as playing a major role in mental illness 
including schizophrenia, bipolar disorder and major depressive disorder (Chen et al., 2015; Karege 
et al., 2012; Muneer, 2017). GSK3b’s role in these types of psychological conditions is thought to 
be attributed to GSK3b’s function in active neurogenesis. During neurogenesis, GSK3b is 
prominent in the canonical WNT pathway and ultimately controls the amount of free b-catenin 
which functions to push the cell through the stages of differentiation (Hur and Zhou, 2010). In 
addition to neurological conditions, GSK3b has also been implicated in diabetes for its role in the 
P13K/Akt pathway and its function in the insulin signaling pathway regarding glycogen synthesis 
(Kleinridders et al., 2014; Saltiel and Kahn, 2001). The many functions of GSK3b further solidifies 
its diversity in both application and substrate specificity. This diversity becomes important when 
identifying or designing enzyme inhibitors that will not serve to inhibit GSK3b in every signaling 
pathway, but rather, in specific pathways. In order to better appreciate GSK3b’s role and activity, 
a closer look at the WNT/b-catenin signalling pathway and participants is necessary.  
1.3 The WNT/b-Catenin Pathway 
The WNT/b-catenin canonical pathway is complex and made up of many key players. The 
pathway itself serves to regulate the expression of genes involved in cell proliferation, 
differentiation and fate specification (Eastman and Grosschedl, 1999). Cells can accomplish this 
regulation by moderating the amount of available b-catenin in the cytoplasm (Figure 1-2). The 
pathway is initiated by extracellular WNT signals which bind to membrane spanning receptors 
(Logan and Nusse, 2004). WNTs are a group of 19-24 different cysteine-rich proteins that are 
secreted or presented on cells and function as signaling molecules (MacDonald et al., 2009; Miller 
et al., 1999).  An extracellular WNT molecule will simultaneously bind two central receptors, 
Frizzled (Fzd) and LRP5/6 (He, 2004; Logan and Nusse, 2004) (Figure 1-2). Both Fzd and LRP5/6 
interact with WNT extracellularly and interact with the b-catenin destruction complex 
intracellularly (Wu and Pan, 2010). The b-catenin destruction complex consists of six known 
protein components; Disheveled (Dsh), Axin, GSK3b, Casein kinase one α (CK1α), Adenomatous 
polyposis coli (APC) and b-Trcp (Logan and Nusse, 2004; MacDonald et al., 2009) (Figure 1-2). 
Dsh is a necessary component of this complex and acts as the initial instigator in response to a 
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WNT signal (Mannava and Tolwinski, 2015). Dsh is recruited by Fzd via its PDZ domain and can 
bind and phosphorylate the LRP5/6 receptor which acts to recruit Axin to the membrane via its 
DIX domain (Gao and Chen, 2010).  Both Axin and Dsh contain DIX domains allowing them to 
form heterodimers which keep the destruction complex at or near the membrane in response to 
WNT (MacDonald et al., 2009). Axin is a scaffolding protein which can simultaneously bind 
GSK3b, CK1α, and b-catenin (Liu et al., 2002; Wu and Pan, 2010). When WNT activates the 
receptors, all of the participants in the b-catenin destruction complex are held in a conformation 
which inhibits GSK3b’s enzymatic activity (McManus et al., 2005). The manner in which GSK3b 
is inhibited within the complex is not yet well understood, although it is noted that GSK3b 
inhibition within the complex does not involve phosphorylation on Ser9 or Ser21 (Ding et al., 
2000; McManus et al., 2005) suggesting that enzyme inhibition occurs via other means possibly 
involving steric hinderance mechanisms. When GSK3b is inhibited, b-catenin accumulates in the 
cytoplasm and can translocate to the nucleus where it acts on transcription factors TCF/LEF 
(Logan and Nusse, 2004). TCF/LEF are upstream of genes which participate in cell proliferation 
and differentiation (Eastman and Grosschedl, 1999). 
When WNT signals are absent, Fzd and Dsh are not bound and subsequently, the b-catenin 
destruction complex, complete with GSK3b, remains active in the cytoplasm (Figure 1-2). Since 
Axin acts as the proverbial anchor by holding the main players near each other (Liu et al., 2002; 
Wu and Pan, 2010) it can associate b-catenin with CK1α and GSK3b. CK1α is a kinase which 
phosphorylates b-catenin at its Ser45 thereby priming it for hyperphosphorylation by GSK3b (Wu 
and Pan, 2010). After b-catenin has been primed, GSK3b will phosphorylate b-catenin at Thr41, 
Ser37, and Ser33 (MacDonald et al., 2009; Wu and Pan, 2010). The phosphorylated Ser33 and 
Ser37 is a docking site for b-Trcp, a ubiquitin ligase, and  
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Figure 1- 2: Canonical WNT/β-catenin signaling pathway.  
Left: When there is no external WNT signal present Axin binds CKIα, GSK3B, β-catenin, and APC. CKIα 
phosphorylates β-catenin priming it for GSK3β hyper-phosphorylation. Once hyper-phosphorylated β-Trcp binds 
β-catenin it can transport it to the proteasome for degradation. Right: When external WNT signals are present 
they bind to receptors LRP5/6 and FZD. Cellular protein DSH binds to both these receptors and also sequesters 
the Axin, CKIα, GSK3β complex to the membrane. This interaction inhibits GSK3b activity towards β-catenin 
decreasing its rate of degradation and allowing it to accumulate in the cytoplasm. β-catenin can then translocate 
to the nucleus and interact with promoters TCF/LEF and increase the transcription of genes involved in cellular 
proliferation.   
will transport phosphorylated b-catenin to the proteasome for degradation (Logan and Nusse, 
2004). APC within the complex has been theorized to release b-catenin from Axin by competing 
for the same binding site and essentially freeing up Axin to bind more b-catenin (MacDonald et 
al., 2009). Axin appears to be the rate-limiting component as it is present in the cell in a limited 
amount (Fraser et al., 2002). Therefore, APCs role as a ratchet becomes paramount to continuing 
the process of hyper-phosphorylating b-catenin. All these individual players work together to 
maintain the levels of b-catenin present in the cell. The feedback loops are intricately designed and 
as such can create disruptions at many different points within the pathway causing the feedback 
loops to deviate from their designated outcomes. The protein players described above are only the 
known components and the pathway and can potentially include other proteins that have yet to be 
described. Of particular interest to researchers is the ability to inhibit this pathway without 
 8 
inhibiting GSK3β functioning in other pathways. One such protein discovered which acts in this 
manner is FRAT.  
1.4 FRAT Function and Role in WNT Signalling 
Frequently Rearranged in Advanced T Cell Lymphoma (FRAT) is a GSK3b binding 
protein that was initially identified as an ortholog of the GSK Binding Protein (GBP) present in 
Xenopus (Yost et al., 1998). Both FRAT and GBP were found to inhibit GSK3b leading to the 
accumulation of b-catenin within the cell (Hagen et al., 2006). FRAT is expressed in all tissue 
types with low detectable levels in the brain (Freemantle et al., 2002). Within the cell, FRAT is 
primarily located in the nucleus and contains a vital N terminal region responsible for its ability to 
shuttle to the cytosol (Freemantle et al., 2002). FRAT appears to have a role within the 
GSK3b/Axin/b-Catenin destruction complex as a result of WNT signaling and actively acts to 
transport GSK3b from the nucleus into the cytoplasm (Bechard et al., 2012). Under normal WNT 
signaling, Dsh interacts with Axin and forms a bridge between Dsh-Axin-GSK3b (Li, 1999) 
(Figure 1-2) which is thought to bring the entire complex to the cellular membrane. However, 
FRAT has been shown to form a stable complex with GSK3b but cannot form a bridge with Dsh 
(Li, 1999). This observation suggests that FRAT does not bind to the β-catenin destruction 
complex and inhibit GSK3β by an interaction with Dsh. This was further confirmed by assays 
which showed that FRAT has the unique ability to inhibit GSK3b activity towards b-catenin 
without inhibiting GSK3b activity towards other substrates such as Glycogen Synthase 1 (GS1) 
(Culbert et al., 2001; Hedgepeth et al., 1999; Thomas et al., 1999) (Figure 1-4). This specificity is 
achieved through the manner in which FRAT1 inhibits GSK3b. FRAT1 and Axin were predicted 
to have overlapping or identical binding sites on GSK3b and thus act in a competitive manner for 
binding (Bax et al.; Dajani et al.; Hagen et al., 2006). Also, FRAT shows an elevated affinity for 
GSK3b in response to PI3K/AKT signaling apart from the WNT pathway (Bechard et al., 2012). 
FRATtide is a 25 mer fragment derived from the GSK3b binding domain of the FRAT2 
homolog (174-196). FRATtide binds to GSK3b in the C terminal region in the channel between 
the helix and the extended loop where a hydrophobic helix-helix ridge groove is located (Bax et 
al.; Dajani et al.) (Figure 1-3). The GSK3b residues located within this hydrophobic groove (Figure 
 9 
1-3 pink sticks) forms Van der Waals interactions with the hydrophobic residues on the binding 
face of FRATtide (Bax et al.) (Figure 1-3 green sticks). Dajani et al. (2003) and Bax et al. (2001) 
were able to show the unique binding modes of FRATtide and a peptide fragment of Axin on 
GSK3b (Figure 1-3). Despite the similarities, the binding sites for FRATtide and Axin are not 
identical and instead are overlapping (Figure 1-3). The FRAT peptide binds in a bent formation 
creating two separate alpha helical segments compared to the Axin peptide which binds in a single 
alpha helical segment. The competition for binding sites on GSK3b between Axin 
 
Figure 1- 3: Comparing the binding sites of FRATtide (orange) and a peptide fragment of Axin (lime 
green) to GSK3b.   
Left: GSK3β (Yellow / PDB 1GNG) bound to FRATtide (Orange). Boxed region shows the hydrophobic residues 
of GSK3β (Pink) interacting with the corresponding hydrophobic residues on FRATtide (Green). Right: GSK3β 
(Yellow / PDB 3ZDI) bound to a peptide fragment of Axin (Green). The binding sites for FRATtide and Axin are 
overlapping but not identical. The crystal structures demonstrate how FRATtide acts to prevent Axin binding.  
peptide and FRATtide is surprising considering that the two peptides share minimal sequence 
identity except for a Leu-Ile sequence within a helix forming region (Bax et al., 2001). The 
discovery of this overlapping of binding sites helped to explain past observations which showed 
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that FRATide was able to block the specific interaction between GSK3b and Axin (Hagen et al., 
2006; Thomas et al., 1999).  
The interaction between FRAT, Axin, and GSK3b is significant because of its ability to act in 
a targeted substrate specific fashion (Figure 1-4). As described above, Axin acts as a docking site 
for GSK3b, b-catenin, and CKIα (Dajani et al.; Liu et al., 2002). Axin also interacts with Dsh (Li, 
1999) and phosphatase PP2A (Hsu et al., 1999). In the absence of an external WNT signal,  b-
catenin is hyperphosphorylated by GSK3b, both of which bind to Axin (MacDonald et al., 2009). 
This robust scaffolding protein has a pivotal role in the b-catenin destruction complex by acting 
as a magnet to bring all the players into close proximity with one another.  Axin itself contains 
many phosphorylation sites and has a higher affinity for b-catenin when it is phosphorylated 
(Willert et al., 1999) adding an additional level of regulation to the complex formation. When 
FRAT/FRATtide is present, it competes for GSK3b binding with Axin so that GSK3b bound to 
FRAT 
 
Figure 1- 4: FRATs interaction with GSK3β and the WNT signalling pathway.  
Figure illustrates the targeted fashion of how FRATtide can inhibit GSK3b activity towards β-catenin without 
influencing GSK3b activity towards other substrates such as GS1. Even in the absence of an external WNT, β-
catenin can still act on promoters TCF/LEF because FRAT prevents GSK3β from associating with 
Axin/CKIα/APC complex.  
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cannot simultaneously be bound to Axin. If FRAT bound GSK3b cannot bind to Axin then it 
cannot congregate in the b-catenin destruction complex (Thomas et al., 1999). As a result, FRAT 
bound GSK3b is not in close enough proximity with primed phosphorylated b-catenin to initiate 
the hyperphosphorylation process (Figure 1-4). This is how FRAT can cause inhibition of GSK3b 
towards b-catenin without causing inhibition of GSK3b towards other substrates. Considering 
GSK3b’s multiple roles in many different pathways throughout the body, this directed inhibition 
becomes increasingly valuable as a potential interaction to exploit. The next logical step is to 
investigate if other scaffold or scaffold-like proteins, such as DISC1, behave similarly. 
1.5 DISC1 Function and Role in GSK3b/WNT Signalling 
DISC1 is a structural scaffold-like protein 854 amino acids long (93.6kDa). It was first 
discovered as segregating with psychiatric illness in a large Scottish family (Blackwood et al., 
2001; Millar et al., 2000). Certain individuals within this family were found to have a genetic 
translocation between chromosomes 1 and 11 creating a truncated version of the DISC1 protein 
(Blackwood et al., 2001). Persons carrying the truncated gene had a higher chance of presenting 
with some form of mental illness (Blackwood et al., 2001). As a result of this original observation, 
DISC1 became the focus of investigation concerning its role in specific psychiatric disorders. 
DISC1 is currently known as a psychiatric risk protein that has been shown to associate with 
schizophrenia, schizoaffective disorder, major depressive disorder, bipolar disorder, and autism 
spectrum disorder (Hikida et al., 2007; Hodgkinson et al., 2004; Johnstone et al., 2011; Kilpinen 
et al., 2008). Its expression is found in a variety of tissue types (Ma et al., 2002) but is 
predominantly found within the brain. The regions of the brain where DISC1 is most prominent 
include;  hippocampus, cortical, cerebellar and olfactory neurons of which both the hippocampal 
and olfactory neurons are capable of producing neural progenitor cells (Lipska et al., 2006; 
Miyoshi et al., 2003). DISC1 primarily functions in neuronal mechanisms including neuronal 
migration (Kamiya et al., 2005), integration of adult neurons into the neural network (Duan et al., 
2007), canonical WNT signaling pathway (Mao et al., 2009) and the development of 
dopaminergic, NMDA and GABA neurotransmission (Hayashi-Takagi et al., 2010; Kim et al., 
2012; Niwa et al., 2010). Despite the primary presence of DISC1 in neuronal type mechanisms, its 
function within each of these pathways is different, and it has been shown to associate with a 
variety of un-related binding partners including NUDEL, α-actinin2, ATF5, GSK3b, and more 
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(Morris, 2003). Due to the vast variety of interacting partners, DISC1 was hypothesized to act 
similarly to a scaffold protein. In general terms, scaffold proteins act to bind many participants of 
a single signaling pathway and bring them into proximity creating multi-protein complexes. This 
often places catalytic components of a signaling pathway near one another to increase access or 
activity. Scaffold proteins do not become consumed by these reactions and instead act primarily 
as a docking site. In this context, DISC1 can be considered a scaffold protein in that it interacts 
with many enzymes of which it is not the substrate including Kal-7, GSK3b, PDE4, Grb2 TNIK 
and NDEL1 (Yerabham et al., 2013). 
Interestingly, DISC1 does not show any sequence similarity to other scaffold proteins 
logged in the protein database (Soares et al., 2011). Its crystal structure has yet to be determined 
but is predicted to contain a distinct and disordered N terminal domain spanning amino acids 1-
350 and a mostly ordered C terminal domain spanning amino acids 350-854 (Miyoshi et al., 2003; 
Soares et al., 2011) (Figure 1-5). The N terminal domain does not share sequence identity to any 
known protein fold and contains a nuclear localization signal (Ma et al., 2002) (Figure 1-5, NLS 
green) and a serine-phenylalanine rich motif (Taylor et al., 2003) (Figure 1-5, SF red). It is 
predicted that these disordered regions give DISC1 its ability to bind to a wide variety of proteins 
(Fink, 2005). However, it is also the disordered regions which makes overexpression and 
purification of recombinant versions of the DISC1 protein difficult (Ma et al., 2002). The C 
terminus is predicted to consist of coiled-coil or helical domains with two UVR domains (Miyoshi 
et al., 2003) (Figure 1-5). DISC1 is predicted to have more than 40 different splice variants with 
the most highly expressed variant being the full-length 93kDa version (Nakata et al., 2009). DISC1 
levels are regulated within the cell by the ubiquitin-proteasome degradation system (Yalla et al., 
2018). It is hypothesized that GSK3b plays a role in DISC1’s rate of turn over by phosphorylating 
the priming sites for the initial binding of ubiquitin E3 ligase enzymes (Yalla et al., 2018). Little 
is currently known concerning the mechanism DISC1 uses to cause inhibition of enzymes, 
specifically of relevance to this thesis is how DISC1 acts to inhibit GSK3b within the WNT 
signaling pathway.  
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Figure 1- 5: Schematic showing the hypothesized structure of DISC1.  
The N terminal region (yellow) is mostly disordered with a nuclear localization signal (NLS) and a GSK3β 
binding domain (red). The generalized location of the DISC1-44mer is depicted (dark green) with the 15-mer 
GSK3β binding domain highlighted (purple). The C terminal region (blue) is helical in structure and contains two 
UVR domains (orange). The C terminal region also contains three self-association domains (SA-pink) allowing 
the protein to form oligomers. The t(1:11) truncation occurs in the middle of the second UVR domain (grey). 
Binding domains for various other proteins are present throughout the protein. Three of the many regions are 
depicted in light green.   
Mao and colleges in 2009 first characterized DISC1’s involvement in the WNT signaling 
pathway. Their studies involved the investigation of mouse construct of DISC1 (mDISC1) with 
purified human GSK3b. They initially realized that mDISC1 was expressed in the dentate gyrus 
and olfactory bulb of mice brains, both areas are known for producing new neurons from neural 
stem cells. When they knocked down mDISC1 in utero, they noticed a significant reduction in 
neural progenitor proliferation which hinted at a potential role for mDISC1 in the process of 
proliferation and thus in the WNT signaling pathway. The role of mDISC1 in this pathway was 
confirmed by a series of knockdown experiments linked to luciferase reporter constructs for the 
transcription factors LEF/TCF. Furthermore, by testing the effect of mDISC1 knockdown in the 
presence of wild-type b-catenin and a degradation-resistant form of b-catenin, Mao and colleagues 
(2009) were able to determine that mDISC1 acts upstream of b-catenin. This observation, 
combined with the knowledge of GSK3b’s role in phosphorylating b-catenin during WNT 
signaling, lead them to investigate mDISC1’s role with mouse GSK3b (mGSK3b). mGSK3β can 
be inhibited by phosphorylation at Ser9 (Cross et al., 1995; Emamian et al., 2004; Park et al., 2013) 
as described above in Figure 1-1, but Mao and colleges (2009) found that overexpression of 
mDISC1 did not influence GSK3b's phosphorylation at Ser9. 
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Conversely, Mao and colleges (2009) saw that mDISC1 overexpression reduced GSK3b 
phosphorylation at Tyr216 (Figure 1-1) which is GSK3b autophosphorylation site required for 
enzyme activity (Cole et al., 2004; Lochhead et al., 2006). They went on to perform in vitro 
association assays to determine if GSK3b and mDISC1 had a direct interaction with each other, 
the results of their experiments determined that two regions of mDISC1 (1-220 and 356-595) 
bound directly to GSK3b (Figure 1-5, GSK3b binding light red). Of these two mDISC1 regions, 
the segment containing residues 1-220 was able to inhibit GSK3b activity towards b-catenin and 
Axin at 0.5 μM whereas the 221-595 regions were only able to cause inhibition at concentrations 
higher than 2 μM. These mDISC1 fragments were not able to inhibit AKT which works against 
the suggestion that mDISC1 may act as a general kinase inhibitor. Mao and colleges (2009) further 
broke down the mDISC1 peptides to obtain a narrower range and found that a 44 amino acid region 
(195-238) was able to inhibit GSK3b with more potency than the commonly known GSK3b 
inhibitor L803-mts (Figure 1-5, 44mer green and purple). 
Additionally, Mao and colleges (2009) used the biophysical assay technology of Surface 
Plasmon Resonance (SPR) to determine that this 44 amino acid region of mDISC1 binds directly 
to human GSK3b. To further narrow down the region responsible for binding they created 
overlapping 15 mer fragments and found that one fragment from region 211-225 was the only one 
which bound to GSK3b via SPR (Figure 1-5, 15 amino acid segment in purple). When they tested 
this short 15mer fragment with GSK3b in a kinase assay, Mao and colleges were able to determine 
that the 15 amino acid region did not inhibit GSK3b. As a result of these experiments, they 
concluded that the 44 mer (195-238) was able to bind and inhibit GSK3b but only a short 15 amino 
acid region of that peptide (211-224), was required solely for binding. This suggested that the 
inhibitor effect of GSK3β lies in the regions outside of the 15 amino acid segment. They further 
confirmed these findings by studying the effects of mDISC1 knockdown complimented with 
GSK3b loss of function and found that cell proliferation was restored further confirming 
mDISC1’s role in inhibiting GSK3b. Lastly, Mao and colleagues finished off their study of 
mDISC1 loss of function by observing mice behaviors and found that mice lacking mDISC1 
exhibited behaviors which approximate to human behaviors characteristic of schizophrenia and 
depression. The study acts as a significant anchor for DISC1 research as it was the first of its kind 
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to determine a direct role for DISC1 in the WNT pathway by determining that DISC1 inhibits 
GSK3b activity. However, the Mao study lacks any attempts to address a mechanism of inhibition 
leaving a niche in the research that this thesis will attempt to explore.  
1.6 Project Outline and Research Objectives 
The nice in the field involves the mechanism of how DISC1 can inhibit GSK3b, therefore, 
gaining insight into this mechanism is a crucial undertone for this thesis. In order to address this, 
the work mainly focuses on comparing FRATtide and DISC1-44mer binding in an attempt to 
identify any possible similarities between their binding sites. Preliminary studies from a group of 
collaborators in Boston utilized enzyme kinetic data to show that DISC1-44mer inhibits GSK3b 
in a manner that was non-competitive for ATP and substrate binding (unpublished). This 
observation shows that DISC1-44mer is not likely binding GSK3b in a fashion that occupies the 
substrate/ATP binding pocket. Since DISC1 is theorized to act in a scaffold-like manner, one valid 
prediction is that DISC1 may interfere with Axin binding similar to FRAT inhibition (Bax et al., 
2001; Dajani et al., 2003). If DISC1-44mer inhibited GSK3b by blocking Axins access then it 
would mean that DISC1-44mer could also be targeted to cause inhibition of GSK3b only within 
the WNT pathway and not towards other potential GSK3b substrates. Better understanding the 
similarities and differences between DISC1 and FRAT inhibition of GSK3b could potentially lead 
to the design of a therapeutic drug modeled after DISC1-44mer that could be targeted to cells 
undergoing neurogenesis. The overall goal of this thesis is to increase our understanding behind 
the kinetic and physical mechanisms with which the DISC1-44mer can inhibit GSK3b. 
1.6.1 Hypothesis 
A short 44-mer fragment of DISC1 binds and inhibits GSK3b in a region which overlaps the 
FRATtide binding site and is distinctly separate from the substrate and ATP binding pocket. 
1.6.2 Objective 1: Optimization of Heterologous Overexpression of Human GSK3b in Bacteria 
Expression of GSK3b through the use of bacterial plasmid vectors continuously yielded a low 
amount of protein. Due to this, optimization of the overexpression protocol was necessary to create 
a reproducible method that would give a high rate of expression for the construct.   
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1.6.3 Objective 2: Optimization of Purification of Human GSK3b 
GSK3b tends to purify along with various contaminating proteins and other impurities. The 
presence of these impurities can potentially cause problems for downsteam studies or assays. Due 
to this, optimization of a purification protocol which utilizes affinity chromatography in order to 
reproducibly achieve a protein product with a level of purity at or above 80% was necessary.  
1.6.4 Objective 3: Investigation of the Inhibition Mechanism of DISC1-44mer Against GSK3b 
using Biochemical and Biophysical Approaches 
Biochemical and biophysical assays are an essential part of understanding the binding 
efficiency and binding kinetics of GSK3β with DISC1-44mer. Surface plasmon resonance (SPR) 
allows the ability to determine the binding capability and efficiency of DISC1-44mer to GSK3β. 
SPR also provided the opportunity to analyze possible details regarding the binding location in 
relation to FRATtide. Kinase activity assays such as ADP-GLO allowed for the determination of 
the overall inhibition effect of DISC1-44mer on GSK3β.  
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2.0 Materials and Methods 
2.1 Constructs 
2.1.1 Plasmid Vector: pST50Trc1-HisNDHFR 
Plasmid vector contains a 6 Histidine tag following a 
T7 promoter with a TEV cleavage site separating the 
tag from the sequence of interest insertion site. The 
plasmid contains ampicillin resistance gene for ease of 
selection.  
 
2.1.2 FRATtide 
 
 
 
 
• Total Amino Acids: 25  
• Molecular Weight: 2.89 kDa 
• Isoelectric point: 10.74
174 196 
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2.1.3 DISC1-44mer  
 
 
 
 
• Total Amino Acids: 44 
• Molecular Weight: 4.53 kDa 
• Isoelectric point: 4.75 
2.1.4 6xHis-TEV-GSK3β 
 
• Total Amino Acids: 447 
• Molecular weight: 49.47 kDa 
• Isoelectric point: 8.89 
2.2 Reagents 
See Appendix A for reagent list 
193 236 
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2.3 Overexpression 
Overexpression was conducted using BL21 DE3 Star Competent E. coli cells. Competent 
cells were transformed into one of two main types of growth media; 2xYT (Bacto-Tryptone 16 
g/L, Yeast Extract 10 g/L, NaCl 5 g/L, 0.1 mg/mL Ampicillin pH 7.0) or TB (Yeast Extract 24 
g/L, Tryptone 20 g/L, Glycerol 4 mL/L, 0.017 M KH2PO4, 0.072 M K2HPO4, 0.1 mg/mL 
Ampicillin). LB media (Bacto-Tryptone 10 g/L, Yeast Extract 5 g/L, NaCl 10 g/L, 0.1 mg/mL 
Ampicillin pH 7.5) and LB agar plates (Bacto-Agar 15 g/L, Bacto-Tryptone 10 g/L, Yeast Extract 
5 g/L, NaCl 10 g/L, 0.1 mg/mL Ampicillin) were used to initiate growth cultures or for plating 
bacterial colonies. The cultures were then induced using Ind1 (Induce with 0.15 mM IPTG when 
OD is between 0.6-0.9 shake at 220 RPM for 16-18 hours at 16-17°C) or Ind2 (Induce with 0.15 
mM IPTG when OD reading is between 0.1-0.2 shake at 220 RPM for 35-40 hours at 16-17°C). 
Following induction and growth, cells were spun down and harvested either in 2L bottles (Nalgene 
2L PPCO Bio Bottle with Sealing Closure (Thermo Fisher # 3120-2006) in H-12000 Rotor at 4700 
RPM for 20 minutes at 4°C) or 1L bottles (Beckman 1L Polycarbonate Centrifuge Bottles (VWR 
#BKA98812) in JLA8.1 Rotor at 5000 RPM for 20 minutes at 4°C). Cell pellets produced from 
this overexpression process were flash frozen using liquid nitrogen and stored at -80°C.  
 
2.4 Protein Purification 
2.4.1 Cell Preparation 
Frozen cell pellets were weighed and resuspended in lysis buffer at varying ratios of pellet 
weight to lysis buffer (Table 2-1 or Table 2-2) volume. The pellets were brought into a 
homogenous state by constant stirring over an ice bath. Following resuspension, cells were lysed 
either by sonication (S3000, ¼” diameter, sonication times, rates, and duty cycles were varied 
based on optimization experimental protocol) or cell disruption (Constant Systems LTD 0.75KW 
with 2-3 run throughs at 25-35 PSI). Lysed cells were pelleted to remove whole cells, nuclei, 
cytoskeleton, and other large unwanted cellular debris. After cell lysis, all preparations were spun 
at 40,000 RPM using an ultracentrifuge (Sorvall WX Ultra Series Ultra Centrifuge, Rotor 
type70Ti) for 60 minutes.   
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2.4.2 Purification 
Protein purification was either completed for a small-scale test of protein expression using 
Ni Sepharose excel histidine-tagged protein purification resin (GE Healthcare #17371201) by 
batch or large-scale test of protein expressing using prepacked columns from GE Healthcare 
(HiTrap SP HP 1mL #17115101, HiTrap SP HP 5 mL #17115201, HiTrap SP XL 1mL #17516001, 
HiTrap SP FF 1mL  #17505404, HiTrap SP FF #17515701, HITrap Q HP 1mL #29051325, 
HisTrap HP 1mL #17524701, HisTrap HP 5 mL #17524801, Superdex 200 Increase 100/300 GL 
# 28990944). Buffers and resins were varied to account for what scale and level of purification 
occurred.    
Table 2- 1: Buffer list for small scale purifications describing abbreviations and components.  
Buffer Components 
Lysis Buffer 
(ssL1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 20 mM Imidazole, 5% Glycerol, 
Pierce Protease Inhibitor  
Wash Buffer 1 
(ssNA1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 20 mM Imidazole, 5% Glycerol 
Wash Buffer 2 
(ssNA2) 
50 mM Hepes pH 7.2, 50 mM NaCl, 20 mM Imidazole, 5% Glycerol 
Elution Buffer 1 
(ssNB1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 250 mM Imidazole, 5% Glycerol 
 
Small-scale purification usually required a 0.5 g sample of the frozen cell pellet 
resuspended in 3-4 mL of lysis buffer followed by cell lysis and spinning as described in the cell 
preparation subsection. Loose resin and batch method were always used for small-scale 
experiments. The buffer compositions for small scale experiments were not varied regularly and 
can be found in Table 2-1. Large-scale purification used anywhere from 10-80 g of frozen cell 
pellet resuspended in a volume of lysis buffer at 3 or 4 times the amount of cell pellet. Large-scale 
purifications follow cell lysis and pelleting described in the cell preparation subsection. Pre-packed 
columns were always used for large-scale experiments. The columns were attached to the ÄKTA 
Pure 25 L (GE Healthcare #29018224) in an order and protocol outlined as PuriA (Lysate was 
applied to SP cation exchange column, elutions were pooled and applied to affinity Ni-NTA 
column) or PuriB (Lysate was applied to NiNTA affinity column, elutions were pooled and diluted 
10:1 with SPA1 then applied to SP cation exchange column). A variety of buffers were utilized 
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for the different experiments and different columns are detailed in Table 2-2. After purification, 
the protein product was incubated with TEV protease in dialysis tubing and dialysis buffer (lsDB: 
50 mM Hepes pH 7.2, 500 mM NaCl, 5 mM BME) at 4°C for 10-16 hours to remove the Histidine 
tag.  
Table 2- 2: Buffer list for large-scale purification describing abbreviations and buffer components.  
Buffer Components 
Lysis Buffer 1 
(lsL1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 20 mM Imidazole, 5% Glycerol, 
Pierce Protease Inhibitor 
Lysis Buffer 2 
(lsL2) 
50 mM Hepes pH 7.2, Pierce Protease Inhibitor 
Lysis Buffer 3 
(lsL3) 
50 mM Hepes pH 7.2, 300 mM NaCl, 5% Glycerol, Pierce Protease 
Inhibitor 
Lysis Buffer 4 
(lsL4) 
50 mM Hepes pH 7.2, 100 mM NaCl, 5% Glycerol, Pierce Protease 
Inhibitor 
Lysis Buffer 5 
(lsL5) 
50 mM Hepes pH 7.2, 300 mM NaCl, 5 mM MgCl2, 1% Glycerol 
NiNTA Wash 
Buffer 1 (lsNA1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 20 mM Imidazole 
NiNTA Wash 
Buffer 2 (lsNA2) 
50 mM Hepes pH 7.2, 50 mM NaCl, 20 mM Imidazole 
 
NiNTA Elution 
Buffer (lsNB1) 
50 mM Hepes pH 7.2, 300 mM NaCl, 250 mM Imidazole 
SP Wash Buffer 1 
(lsSPA1) 
50 mM Hepes pH 7.2 
SP Wash Buffer 2 
(lsSPA2) 
50 mM Hepes pH 7.2, 50 mM NaCl 
SP Elution Buffer 
(lsSPB1) 
50 mM Hepes pH 7.2, 1M NaCl 
Gel Filtration 
Buffer 1 (lsGF1) 
50 mM Hepes pH 7.4, 500 mM NaCl, 2 mM MgCl2, 1 mM TCEP 
 
Gel Filtration 
Buffer 2 (lsGS2) 
50 mM MES pH 6.5, 175 mM NaCl, 1 mM MgCl2, 10 mM DTT, 5% 
Glycerol 
 
2.5 SPR Assay 
SPR studies were conducted using the Reichert 2 channel single flow cell (Model: 2SPR). 
The Nickel Nitrilotriacetic Acid (NiNTA) Sensor Chip (Reichert CA# 13206065) was first 
prepared by flowing a NiSO4 solution overtop to capture the Ni+ ions and primed it for protein 
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capture. SPR assay was conducted using the buffers detailed in Table 2-3. Initially GSK3b was 
diluted in RB1 and captured onto the Ni-coated surface. After GSK3b was captured, the buffer 
was run over the surface of the chip until the amount of protein dislodged by the flow of buffer 
(drift) fell below 5 RU/min. Blanks were injected using RB1 to establish a baseline for background 
binding. Then the synthesized 25 Amino Acid fragment of FRAT (FRATtide) from GenScript (Lot 
#: 93874160001/PE1490) or the synthesized 44 Amino acid fragment of DISC1 (DISC1-44mer) 
from NEO BioLabs (P12485D hd1-44mer, catalog No 249346 with purity rating of 96.5%) were 
injected and flown over the top. DISC1-44mer was dissolved in KB1, then diluted with DB1 and 
brought to final volume with RB1. FRATtide was dissolved in RB1. Results were analyzed using 
TraceDraw software. Chip surface was regenerated with SB and RGB and a 0.5 M NaOH solution. 
Table 2- 3: Buffer abbreviations and components used for SPR studies.  
Buffer Components 
Running Buffer (RB1) 50 mM Tris pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.01% Tween 20, 
1 mM TCEP 
Kinase Buffer (KB1) 50 mM Tris pH 7.5, 5 mM MgCl2, 0.01% Tween20, 1 mM TCEP 
Dilution buffer (DB1) 50 mM Tris pH 7.5, 5 mM MgCl2, 300 mM NaCl, 0.01% Tween20, 
1 mM TCEP 
Stripping Buffer (SB) 20 mM Na-Phos pH 8.5, 300 mM NaCl, 50 mM EDTA  
Regeneration Buffer 
(RGB) 
50 mM Hepes pH 7.2, 300 mM NaCl, 250 mM Imidazole  
2.6 ADP-GLO 
ADP-GLO analysis was conducted with the ADP-GLO kit and reagents from Promega 
(CA # V6930). Pre-Mix buffer (150uM ATP, 25nM GSK3b, 1X RxnB1) was prepared with ATP 
and GSK3β. Varying reaction mixtures in reaction buffer (RxnB1: 50 mM Tris pH 7.5, 5 mM 
MgCl2, 0.01% Tween 20, 3 mM DTT)  were set up in a 96 well plate with the synthetic GSK3β 
substrate GSP2 from SignalChem (Catalogue #: G50-58, Lot #: 01059-3, MW: 3029.13 Da. Purity: 
95.85% by HPLC) alone or with the synthetic substrate inhibitor DISC1-44mer from NEO 
BioLabs (P12485D hd1-44mer, catalog No 249346 with purity rating of 96.5%). The pre-mix 
buffer was added to the reaction mixture in the 96 well plate and incubated for a set amount of 
time depending on the parameter being measured. The incubation time allowed for the reaction to 
occur. To stop the reaction at a set point, 5 μL of ADP-GLO reagent and 5 μL of the reaction were 
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mixed an allowed to incubate for 60 minutes. The ADP-GLO reagent stops the reaction and 
simultaneously remove any unused ATP. Detection followed the stop reaction set by adding 10 
μL of the ADP-GLO Detection Reagent into the mixture and allowing to incubate for 30 minutes. 
The ADP-GLO Detection reagent stoped the ATP depletion reaction and converted the ADP in 
solution to ATP which is further converted to light by luciferase. The luciferase activity is 
quantified by a luminescence plate reader (SynergyHT Luminescence Plate Reader).  
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3.0 Objective 1: Optimization of Heterologous Overexpression of Human GSK3b 
in Bacteria 
 This chapter focuses on detailing the efforts made to improve the overall amount of protein 
produced at the stage of overexpression. Overexpression, in the context of this thesis, refers to the 
act of using an IPTG inducible plasmid containing a copy of His-GSK3β in competent E. coli 
cells. The GSK3b protein used is a eukaryotic protein which tends to be toxic and thus challenging 
to overexpress in bacterial systems. Also, the protein contains some hydrophobic regions making 
aggregation a potential issue. This chapter outlines the experiments conducted in an attempt to 
alleviate some of these issues and increase the overall amount of protein produced at this level.   
3.1 Results 
3.1.1 Comparison of Ind1 and Ind2 
The main differences between Ind1 and Ind2 involve the induction point and the growth 
duration. Ind1 induces between 0.6 to 0.9 OD then allows the cells to grow over a period of 16-18 
hours. Ind1 is compared to Ind2 which induces between 0.1 and 0.2 OD then allows the cells to 
grow over a period of 35-40 hours (Table 3-1). Both induction conditions were adapted from 
previously established protocols and compared herein to determine which procedure is better 
suited for the growth of  cells containing a GSK3b expressing plasmid. The two induction 
conditions were compared between two common media types; 2xYT and TB. In general, media 
compositions were generated to support bacterial growth through the logarithmic growth phase. 
Both 2xYT and TB media contained Tryptone and Yeast Extract which act as a source of carbon, 
nitrogen, vitamins, minerals and amino acids (Kram and Finkel, 2015). The main difference 
between the two media types is the buffering component in TB media. The potassium phosphate 
buffer in TB media, acts to prevent cell death and increase plasmid yield by extending the 
exponential phase of E. coli while simultaneously resisting the increase in pH which occurs as a 
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 result of metabolism of amino acids (Kram and Finkel, 2015). Higher points of induction 
occurring within mid to late log phase (OD600 0.6-0.9) were hypothesized to be optimal as that is 
the time in which bacterial cellular growth is highest, ensuring that protein production will be at 
its peak. However, the use of lower induction points in the early log phase (OD600 0.1-0.2) was 
theorized to be beneficial overall as it allowed for protein production to occur during a time when 
the cellular growth rate would be slower which may give sufficient time for translated proteins to 
fold.   
Table 3- 1: Summary of the main differences between Ind1 and Ind2. 
 Induction OD [IPTG] Temperature Duration 
Ind1 0.6-0.9 0.15 mM 16-17°C 16-18 hours 
Ind2 0.1-0.2 0.15 mM 16-17°C 35-40 hours 
  
Results show GSK3b present in each of the four test conditions. ImageJ analysis determined 
that TB media has the propensity to produce GSK3b at a slightly higher amount (~30%) when 
compared to 2xYT (Figure 3-2). However, TB also appears to produce a higher level of 
contaminants compared to 2xYT (~15%). The comparisons between Ind1 and Ind2 concerning the 
amount of GSK3b produced shows that Ind2 can produce more GSK3b but the overall difference 
in intensity is minimal. When considering the best use of time and materials Ind1 is the more 
effective method. When considering the downstream effects of overexpression on purification the 
proportion of contaminants needs to be considered. For these reasons, 2xYT with Ind1 was 
determined to be the most efficient of the four methods investigated.  
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Figure 3- 1: 12% SDS gel showing GSK3b among the four conditions tested comparing Ind1 and Ind2  
Each elution fraction (E1-E3) is the result of a 1L preparation of cells resuspended in 15 mL of ssL1 and lysed 
via sonication (microtip, 3x3 minute sets at 50% duty cycle). Lysed cells were spun down at 14,000 RPM for 40' 
then bound via batch method to 100 μL of NiNTA resin and allowed to incubate for 40 minutes at 4°C. The resin 
was washed with 1.5 mL of ssNA1 and eluted with 300 μL ssNB1. ImageJ analysis of the GSK3b band for each 
elution fraction was added together for each condition. Overall intensity was normalized using the intensity of 
the 75 kDa band in the ladder and compared to draw conclusions. GSK3b is indicated in the figure by the arrow.  
3.1.2 Comparison of Growth Vessels 
The design of growth vessels can affect protein overexpression. Ultra Yield FlasksTM are 
designed with notches in the base to increase aeration for optimal bacterial growth. To test whether 
these flasks help with GSK3b production by E. coli cells, a series of experiments was designed to 
investigate if the level of protein expression varies between cultures grown in standard Erlenmeyer 
glass flasks and cultures grown in Ultra Yield FlasksTM. ImageJ analysis of band intensity 
demonstrated that cell cultures grown in the aerator flasks produced 1.5X more GSK3β than cell 
cultures grown in the glass Erlenmeyer flasks (Figure 3-1). It was suggested that one single batch 
of 1L cell pellets grown in the Ultra Yield FlasksTM should contain a relatively similar amount of 
GSK3β protein as one single batch of 2L cell pellets grown in the standard Erlenmeyer flasks. 
Considering the minimal difference, the practice of using 4L Erlenmeyer flasks to grow 2L of cell 
culture was continued.  
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Figure 3- 2: 12% SDS gel comparing protein expression between cultures grown different growth vessels. 
Both preparations consisted of 1L of 2xYT media prepared using Ind1. Each fraction depicted in the gel is the 
result of 0.5 g of cell pellet resuspended in 1 mL of ssL1 and lysed with the addition of lysozyme and incubation 
at 37°C for 30 minutes. Lysed cells were spun down at 15,000 RPM for 40 minutes then bound via batch method 
to 25 μL of NiNTA resin and allowed to incubate for 40 minutes at 4°C. The resin was washed with 3 mL of 
ssNA1 and eluted with 100 μL of ssNB1.  Flow-through fractions consist of a sample of lysate that did not bind 
to the NiNTA resin. The wash fractions consist of a sample after the resin was washed with ssNA1. Elution 
fractions consist of a sample after the resin was eluted with ssNB1. ImageJ analysis of the GSK3b band in the 
elution fractions was conducted. GSK3b is highlighted in the figure with rectangular boxes. 
3.1.3 Reduce GSK3b Toxicity to Bacteria  
In some instances, certain proteins can be toxic to the bacterial host. Toxicity of eukaryotic 
proteins is one of the many possible explanations for low gene expression (Gubellini et al., 2011). 
Toxicity, in this context, is a term used to explain low expression levels of recombinant genes 
when the proteins encoded by those genes are eukaryotic kinases. To further investigate the 
possibility that the kinase activity of GSK3b is the cause of its toxic effect on BL21 cells, 
overexpression was conducted with varying concentrations of Lithium Chloride. Lithium chloride 
(LiCl) is a known inhibitor of GSK3b (Beaulieu, 2007). Since expression levels of GSK3b in 
BL21 are lower than desired and considering that GSK3b is a eukaryotic kinase, it was 
hypothesized that GSK3b is having a toxic effect on the bacteria. Given this, it was postulated that 
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the addition of LiCl to the growth media will increase the overall protein yield by inhibiting the 
function of GSK3b and thereby limiting its toxic effect.  
 
Figure 3- 3: 12% SDS gel and western blot analysis of pre- and post-induction samples taken from 100 mL 
cultures grown with LiCl.  
The experiment was conducted under the induction conditions of Ind2.  Samples were taken from the Post-
induction condition after the dedicated growth duration. Samples taken from the Post-induction condition were 
corrected for volume using OD measurements to be representative of having the same number of cells as the 
sample taken from the pre-induction condition for adequate comparison. Cells were not lysed and instead run 
directly on an SDS gel after being heated with SDS loading buffer. The GSK3b band is indicated by the 
rectangular box. B: Western Blot analysis of the same samples depicted in A. Samples were incubated with 
antibodies against anti-GSK3b (amino acid 1-160 Dilution 1:6000) and visualized with secondary antibody (Anti-
mouse dylight 680 in Dilution 1:10000) than detected with G-Box UV imaging.   
The results showed a visible GSK3b band that appeared in all the test conditions (Figure 
3-3 - A). GSK3b presence was further confirmed by western blot analysis using antibodies against 
the protein GSK3b itself (Figure 3-3 - B). ImageJ analysis of the Coomassie-stained gel showed 
that LiCl in the media produced little effect on overall expression as all the conditions appeared to 
produce a relatively similar amount of GSK3b. Western blot analysis was also unable to 
distinguish a difference in levels of GSK3b expression among the different test conditions. The 
conclusion from this series of experiments was that the addition of LiCl up to and including 
concentrations of 20 mM to cell culture media is not overly helpful in increasing the 
overexpression levels of this specific GSK3b construct.   
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3.2 Discussion 
3.2.1 Growth Components and Protocols 
3.2.1.1 Comparison of Ind1 and Ind2 
 When only considering the amount of GSK3b alone, TB media with Ind2 appeared to be 
the best condition. However, extra considerations needed to be addressed concerning time 
restraints and chaperone levels. The longer cells remain in long-term stationary growth phase, the 
more likely they are to undergo mutation as a result of oxidative stress (Kram and Finkel, 2015). 
Mutations of this variety are unpredictable and have the potential to result in lower levels of protein 
expression. Factoring this information into the comparison between Ind1 and Ind2 it can be argued 
that since both induction conditions produce protein in relatively similar amounts, Ind1 would be 
preferable given that the period cells spend in long-term stationary phase is lower. In addition to 
overall time, deliberations needed to be made for the level of contaminants present. TB media has 
the unique ability to extend the exponential growth phase of E. coli (Kram and Finkel, 2015) which 
allows for increased protein expression. However, it can be suggested that along with this 
increased growth phase there is an inherent increase in the expression of native E. coli proteins 
including folding chaperones. Although these chaperones do not play a direct role in the 
overexpression mechanism, they are noteworthy when observing the project as a whole as they 
will need to be eventually removed in subsequent purification steps. Ideally, more chaperones 
would be beneficial to help with folding and lessen any potential aggregation. However, further 
investigation into purification steps has shown that these chaperones have a higher tendency to 
stick to GSK3b and can be difficult to remove.  The best scenario for overexpression would be a 
condition where the chaperones are expressed well to aid with folding but not overexpressed at a 
comparable rate to overexpressed protein. When comparing the ratio of GSK3b to Contaminant60, 
TB/Ind2 was the highest overall. 2xYT/Ind1 had the second highest ratio.  2xYT/Ind1 and TB/Ind2 
were similar. Collective analysis of all the points suggests that 2xYT/Ind1 is the most useful 
condition to produce an acceptable amount of GSK3b without overloading the system with cellular 
proteins and chaperones.  
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3.2.1.2 Comparison of Growth Vessels 
The Ultra Yield FlasksTM were more efficient at increasing protein expression per liter of 
cell media prepared. This is the case because the design of the Ultra Yield FlasksTM creates an 
environment with greater air exchange for the bacterial cells. The shaking of cultures within these 
flasks creates an equal distribution of nutrients to the contained cells as well as an increase infusion 
of oxygen. If oxygen levels are not evenly distributed to all cells then the result for aerobic bacteria 
such as E. coli is cell death ultimately lowering the overall yield of protein production (Kram and 
Finkel, 2014). This explains why the amount of expression from cells grown in the Ultra Yield 
FlasksTM flasks (2.5 L) is more comparable to expression from cells grown in a 4L flask than from 
cells grown in a 2L flask. The ratio of air to media also plays a role in the amount of air exchange 
occurring (Kram and Finkel, 2014). Ideally the best conditions for bacterial growth, and 
subsequent protein expression, would be to use the notched design of the Ultra Yield FlasksTM with 
a high air to media ratio.  
3.2.2 Toxicity and Leaky Expression 
3.2.2.1 Lithium Chloride 
The results from this experiment suggest that LiCl in the media is unable to increase 
GSK3b expression levels since expression of GSK3b was consistent across the different 
concentrations of LiCl. The concentrations used were based on values of LiCl adapted from a study 
which showed that 20 mM of LiCl was sufficient to entirely suppress GSK3b activity (Klein and 
Melton, 1996). However, it is important to note that the study used GSK3b in solution, not GSK3b 
contained within the cellular membranes of a bacterial host. It is possible that in order to see any 
changes in expression as a result of inhibition, a concentration greater than 20 mM of LiCl is 
necessary. Given that each cell contains multiple copies of the offending protein and a single unit 
of media solution is dense with cells it can be assumed that the overall concentration of GSK3b 
within the growing culture is much higher than the amount of GSK3b used for the assay in the 
Klein et al. study (Klein and Melton, 1996). Therefore, 20 mM of LiCl may not have been 
sufficient to effectively inhibit enough enzyme units to influence any effect on toxicity. It is also 
possible that LiCl is unable to cross the cell membrane and act directly on GSK3b. Further activity 
studies of proteins purified after being grown in media containing LiCl will further clarify if the 
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LiCl actively inhibits the enzyme units within the cells in the media. These further studies would 
allow for proper conclusions to be drawn regarding GSK3bs activity and its influence on 
expression levels. At the current stage, the only conclusion that can be drawn from the data is that 
the addition of LiCl to the media does not positively increase GSK3b expression.  
 Although LiCl was ineffective under the conditions in which it was used, there are still 
other ways to potentially reduce recombinant protein toxicity to E. coli cells. The addition of 
ethanol at 1%-4% v/v at the time of induction has been shown to be effective at increasing toxic 
protein yield in some cases (Chhetri et al., 2015). Alternative methods of decreasing recombinant 
protein toxicity to E. coli include manipulations to the gene sequence. One group has successfully 
shown abundant overexpression of a toxic eukaryotic protein in E. coli by including a leader 
sequence that correlated to the S-loop of the bacterial chaperone GroES. This leader sequence is 
known to interact with bacterial chaperone GroEL and increases the recombinant proteins affinity 
for GroEL. Thereby increasing the rate at which the recombinant protein will undergo proper 
folding and in doing so, decrease the toxic consequence of the protein (Donnelly et al., 2001). 
Given GSK3b’s low expression levels, it is possible that the use of a leader sequence with affinity 
to GroES may help increase the overall yield in a similar fashion. Additionally, alternative cell 
lines are available that specialize in expressing toxic proteins including C41(DE3) or C43(DE3). 
The strains claim to be useful in expressing toxic and membrane proteins from all classes including 
eukaryotes. The cell line contains a mutation that prevents cell death in the presence of toxic 
recombinant proteins. These constructs could potentially decrease the toxic effect GSK3b has on 
the bacterial expression system.  
3.2.3 Leaky Expression 
Leaky expression of the induction system was witnessed in previous experiments (Figure 
3-3). Leaky expression is problematic as it can act as an initiator of aggregation. The proteins 
expressed earlier on are likely in an aggregated form and this aggregation can trigger more 
aggregation of newly synthesized proteins. One potential suggestion for further optimization to 
reduce leaky expression includes attempting overexpression in bacterial cell lines other than 
BL21(DE3). For instance, BL21(DE3)pLysS includes the pLysS plasmid which contains a T7 
lysozyme. This lysozyme aims to reduce basal levels of gene expression before IPTG induction. 
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Additionally, the addition of glucose to the growth media may also prove effective at reducing 
leaky expression. Leaky expression can occasionally be attributed to the lack of a carbohydrate 
source in the media which increases the presence of activator proteins involved in alleviating lac 
operon repression (Grossman et al., 1998). Addition of glucose at a rate of 1% to the growth media 
has been shown to eliminate this form of leaky expression for the IPTG inducible Lac operon 
system (Grossman et al., 1998).  Both methods are worth investigating to analyze their potential 
for increasing protein yield levels.   
3.2.4 Summary  
  The work conducted within the confines of this thesis served to investigate specific issues 
involved with overexpression such as media preference, growth vessel preference, toxicity, and 
leaky expression. While the thesis was able to bring the protocol to a workable point, more 
optimization will be necessary in order to get the construct to express at a level required for 
crystallization protocols. If none of the suggestions discussed above proves to be effective in 
increasing GSK3b yield, future research may have to investigate using Baculovirus/Insect Cell 
lines or plant-based platforms in place of bacterial cell lines. Both insect and plant-based 
expression systems have shown an increased level of expression for difficult recombinant proteins. 
These systems seem to alleviate the issues surrounding inclusion bodies and the presence of 
persistent folding chaperones which are commonly encountered with the use of bacterial cell lines 
(Gecchele et al., 2015). However, it should be noted that while both insect and plant-based 
expression systems can produce recombinant protein at a higher yield, insect cell lines are less 
cost-effective and plant-based systems require a long time to establish.  
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4.0 Objective 2: Optimization of Purification of Human GSK3b 
This chapter focuses on detailing the efforts made to improve the overall amount of protein 
retrieved during the purification stage. Purification, in the context of this thesis, refers to the 
process of separating GSK3b from other proteins present in the cell lysis mixture. Purification 
includes the physical process of cell lysis and multiple components of column purification 
including column order, resin type, wash buffer components. The overall goal of the objective was 
to improve upon the existing purification protocol to obtain a larger yield of GSK3b that has a 
high purity level for use in other experiments or assays.  
4.1 Results 
4.1.1 Cell Lysis 
4.1.1.1 Sonication Duration 
Sonication is the use of sound waves to break open bacterial cells and release the cellular 
components from inside. Too little sonication cause cells to remain intact whereas too much 
sonication can potentially cause degradation of the desired proteins (Shrestha et al., 2012). One 
hypothesis developed to explain the low protein yield observed is a suboptimal amount of 
sonication resulting in pelleted or degraded protein. To address this hypothesis, a time course 
sonication study was conducted (Figure 4-1) with the intention of identifying a time point in which 
a distinct GSK3β band could be seen in the supernatant fraction and less in the pellet fraction. The 
presence of a clear GSK3b band in the supernatant fraction would indicate that the majority of 
protein in the lysate could be found in the soluble fraction and not be pelleted in the insoluble 
fraction. 
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Figure 4- 1: Time course study for sonication.  
Cells grown in 2xYT and induced using Ind2 were resuspended in lsL2 buffer and set up to be sonicated by a ¾” 
probe at 50% duty on a maximum strength output of 5 using a Branson Sonifier VC300. Samples of the lysate 
were collected at 1 min intervals for 15 minutes (samples from 2 min to 6 min are not shown in the figure above). 
Each of the samples was spun down at 15,000 RPM, and the pellet and supernatant fractions were analyzed on a 
12% SDS gel. ImageJ analysis of band intensity was attempted to determine a time point where GSK3b could be 
seen in the supernatant fraction.   
 
Figure 4- 2: (A) Purifiable protein after 15 and 20 min. (B) Western blot analysis of the sonication series. 
(A) 50 g cell pellet that was grown in 2xYT media and induced using Ind2 were resuspended in 200 mL of lsL2 
buffer and set up to be sonicated by a ¾” probe at 50% duty cycle on a maximum strength output of 5 using a 
Branson Sonifier VC300. Two replicates were conducted under identical circumstances expect the duration of 
sonication. Both samples were processed using PuriA. Samples on the left (t=15) had 15 minutes of sonication 
whereas samples on the right (t=20) had 20 minutes of sonication. (B) Western blot analysis of samples run during 
sonication series as depicted in Figure 4-1. The primary antibody was targeted against the Histidine tag at room 
temperature for 2 hours (See Appendix B).  
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Results from this series of experiments showed a faint band, suspected to be GSK3b which 
could begin to be identified in the supernatant fraction around 7 minutes while the intensity of the 
suspected GSK3b was most prominent at 15 minutes (Figure 4-1). However, it can be observed 
that the correlating band for GSK3b in the pellet fraction is also most prominent at 15 minutes 
(Figure 4-1). For the time points higher than 15 minutes, the SDS analysis does not show a distinct 
band correlating to GSK3b (results not shown). The whole cell lysis approach made it difficult to 
easily identify or confirm the presence of GSK3b at each of the time points. To confirm the 
presence of GSK3b in these fractions, western blot analysis was conducted (Figure 4-2 B) on the 
same whole cell preparations presented in Figure 4-1.  Antibodies used for Western Analysis were 
targeted against GSK3b (data not shown) and the Histidine tag to add confidence to the 
confirmation of GSK3bs presence in both the supernatant and the pellet fractions. Western blot 
analysis was able to positively confirm the presence of GSK3b in each fraction from t=2 to t=17 
but was unable to distinguish a difference in band intensity as depicted above (Figure 4-2 B).  
To further investigate the difference in sonication times in more quantifiable terms of 
soluble protein, identical samples were compared for sonication times of 15 minutes and 20 
minutes (Figure 4-2 A). Chromatogram peak height (data not shown) and ImageJ analysis from 
the NiNTA-purified samples, confirmed that the overall amount of retrievable GSK3b after 20 
minutes of sonication is less than the amount retrieved after 15 minutes of sonication (Figure 4-2 
A). It should also be noted that the comparison between the two sonication conditions showed that 
increased sonication above 15 minutes yields a resulting NiNTA fraction with an increased number 
of protein species present between 50 and 25 kDa. Also, the 60 kDa chaperon in the 20-minute 
sonication condition appears to be more prominent. 
The results from the sonicator comparison analysis suggest that sonication times at 20 
minutes or above are detrimental to the amount of protein product which remains in a purifiable 
state. While 15 minutes appears to be superior to 20 minutes, it can still be argued that the amount 
of protein retrieved is lower than expected for the number of cells processed. The western blot 
analysis of the timed series shows that GSK3b is present in the supernatant fraction after only 2 
minutes and is most noticeable on the SDS gel at 7 minutes suggesting that sonication times less 
than 15 minutes may be able to retrieve even higher amounts of purifiable GSK3b. Additional 
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studies conducted with 10 minutes of sonication time proved to be less effective at retrieving 
GSK3b when compared to preparations conducted using 15-minute sonication protocols (results 
not shown). Overall, in the event of sonication alone as a cell lysis method 15 minutes appears to 
be the most beneficial when compared to 20 minutes and 10 minutes for 25-50 g of cell pellets 
resuspended in lysis buffer at a ratio of 4:1.  
4.1.1.2 Cell Disruptor Comparison 
 Sonication as a cell lysis tool possesses the potential to be too aggressive on cells which 
may lead to aggregation of protein products. In comparison, cell disruption acts by using pressure 
and force to burst open cells which has the potential to be less detrimental to protein yield when 
used in the proper proportion (Vanderheiden et al., 1970). This series of experiments attempted to 
compare the effectiveness of sonication to cell disruption as they pertain to cell lysis. It is 
hypothesized that a higher yield of purifiable protein can be obtained when the method of cell lysis 
used is cell disruption instead of sonication. Since cell disruption is thought to be a milder 
approach, there should subsequently be less protein degradation or aggregation. This series of 
experiments compared the yield of two separate purifications which only varied in the type of cell 
lysis method utilized; sonication or cell disruption.  
 The NiNTA elution fraction and 100% reverse wash fractions depicted above (Figure 4-3) 
illustrate the main differences between the lysis methods under investigation. The NiNTA elution 
fractions shows what protein species are retrieved when the affinity column is the first to be 
introduced to the lysate. The 100% Elution Reverse Wash occurs after elution is complete, it is a 
subsequent 100% Elution wash in the up-flow direction. The purpose of the reverse wash is to 
determine if any protein species became stuck above the filter of the column and as such were 
unable to be washed off in the downward direction. Reverse wash analysis is an additional 
indication of potential protein aggregation within the lysate.  
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Figure 4- 3: Comparison of purifiable protein between cell lysis with cell disruption and sonication.  
12% SDS gel results of two separate purifications. 10 g (cell disruptor-left) and 9 g (sonication-right) of cells 
grown in 2xYT and induced via Ind1 were resuspended in 15 mL of lsL3 and lysed. Lysed cells were spun down 
at 40,000 RPM for 60 min then purified according to PuriB. 1mL column was used and washed with 25 mL of 
lsNA1, then washed with 10 mL lsNA2. Elution occurred with Gradient and 10 mL elution buffer lsNB1. The 
gels displayed show the NiNTA elution fraction and the 100% reverse wash fraction. Cells that had undergone 
lysis via cell disruptor underwent three rounds of cell disruption at 25 PSI. Cells that had undergone lysis via 
sonication underwent sonication with a ¾" probe of the S3000 in timed increments of 2 seconds on/2 seconds off 
for a total process time of 3 minutes.    
The cell disruptor analysis shows a clear band for GSK3b with the typical 60, 70 and 25 
kDa contaminants frequently seen eluting together. The 100% elution reverse wash fraction from 
this analysis is clear showing no protein bands which indicates that there is little to no aggregates 
stuck above the filter. The sonication analysis shows GSK3b in the elution fraction with the typical 
60, 70 and 25 kDa contaminants. However, protein bands at 100 and 80 kDa along with multiple 
bands between 37 and 25 kDa can be seen, that were not present in the elution fraction from the 
cell disruption analysis. The presence of these additional bands makes the elution look dirtier 
which is undesirable as it can be difficult to remove these bands during later stages of purification. 
In addition, the 100% elution reverse wash fraction from the sonication analysis shows GSK3b 
and the 60 and 70 kDa contaminants (Figure 4-3) suggesting that the sonication process may be 
causing some level of aggregation of the proteins or the protein complex in solution. Overall, both 
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methods of cell lysis can be utilized effectively, but cell disruption appears to cause less 
aggregation and produce a cleaner protein product after affinity column purification. 
4.1.2 Column Purification 
4.1.2.1 Purification History 
Initial work by previous lab members established a protocol whereby GSK3b was 
expressed in a bacterial culture grown in TB media and induced via Ind2. The initial purification 
protocol focused on PuriA whereby the lysate was applied to cation exchange resin (SP-HP) before 
its application to affinity resin (NiNTA). However, the final product after the NiNTA purification 
could only generate a small fraction of protein with an approximate purity level of 60%. When the 
protein product at this stage was applied to a gel filtration column, the purity level increased to 
>90%, but the overall yield decreased to minimal amounts. The primary contaminants persistently 
seen in this fraction were three substantial bands that appeared to purify along with GSK3b 
repeatedly. These contaminants are generally referred to within this thesis by their weights of 60 
kDa (Contaminant60), 70 kDa (Contaminant70) and 25 kDa (Contaminant25). These 
contaminants often remained associated with GSK3b after histidine tag cleavage and subsequent 
rounds of Ni-NTA purification. In some cases, the contaminants even remained associated with 
GSK3b throughout the process of gel filtration. This observation strongly suggests that 
Contaminant60 and Contaminant70 are bound directly to GSK3b in some capacity. 
Further studies within the lab were able to employ Mass Spectrometry technology to 
confirm that Contaminant60 is the bacterial chaperone GroEL. GroEL is known to aid in folding 
of proteins between 20-60 kDa that contain hydrophobic regions (Joanna L. Feltham and Lila M. 
Gierasch, 2000). It is assumed that Contaminant70 is likely a bacterial chaperone as well. It has 
been documented that DnaK is a 70 kDa bacterial chaperone that tends to co-purify with 
recombinant proteins (Hellebust et al., 1990; Rial and Ceccarelli, 2002).  Like GroEL, DnaK also 
has a wide range of substrates that range in size and isoelectric point making GSK3β a likely 
substrate (Calloni et al., 2012). These chaperones and/or contaminants could be partially removed 
by cation exchange chromatography if run before affinity purification with Ni-NTA (PuriA). 
Within the confines of this thesis these contaminants and/or chaperone bands will collectively be 
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referred to as contaminants. Further attempts at optimizing purification aim to address the removal 
of these bacterial contaminants to increase the fraction purity without sacrificing protein yield.  
4.1.2.2 Optimization of Cation Exchange Resin 
 The original protocol utilized SP-HiTrap (SP-HP) resin for the cation exchange purification 
step. SP-HP is useful as it has a decent capture ability, but it was problematic due to the smaller 
resin bead size which created a limitation in running speeds for viscous lysates of large volume.  
The ÄKTA system monitors column pressure and can adjust the speed of application to avoid 
overpressure conditions that may damage the column bed. As a result, the flow rates experienced 
with the SP-HP resin were slow which increased the overall amount of time the protein was sitting 
in the lysate. Increased time of protein in lysate is problematic as it has a higher potential for 
protein degradation via proteases. To address this issue, two additional types of SP resin beads 
with different qualities were tested. The different varieties examined include; SP-Fast Flow (SP-
FF) resin and SP-Extra Large (SP-XL). SP-FF is distinct from SP-HP as the beads have a larger 
diameter (90uM compared to 34uM) allowing for faster flow rates. SP-XL is similar to SP-FF in 
that it too has a bead with a 90uM diameter, but it is distinct from the SP-FF in that it contains 
extra-long surface extenders on each bead to allow for greater lysate interaction. 
The amount of GSK3b produced from purification with SP-FF had a band intensity from 
ImageJ analysis that was 1.5X greater than the amount of GSK3b obtained from purification with 
SP-XL (Figure 4-4). The bacterial contaminants (Contaminant60, Contaminant70, and 
Contaminant25) were not seen in the elution fraction when the SP-FF column was used. In 
comparison, the contaminants were seen in the early stages of elution (Elution 1 for SP-XL in 
Figure 4-4). Both columns appeared to be equally efficient at removing large amounts of the 
contaminating bands, but the SP-FF column was more effective at retaining GSK3b. As a result 
of this series of experiments further large-scale purifications were conducted using 5 mL SP-FF 
Sepharose columns in place of the SP-HP columns. When tested in large-scale environments, the 
usage of SP-FF columns did allow for larger volumes of cell lysate to be processed at a faster rate 
while retaining a satisfactory proportion of GSK3b. 
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Figure 4- 4: Comparison between two types of cation exchange columsn (XL and FF). 
4g of cells grown in 2xYT were resuspended in 16mL of lsL3 and lysed via sonication method. Lysed cells were 
spun down at 40,000 RPM for 40 mins and purified according to PuriA protocol. The lysate was bound to a 1mL 
column and washed with 25mL of lsNA1 buffer. The column was eluted using 10mL of lsNB1 buffer. The 12% 
SDS gel depicts the NiNTA elution fractions from preparation where SP-XL was used as the cation exchange 
column (left) and where SP-FF was used as the cation exchange column (right). Image J analysis of band intensity 
for GSK3b was conducted and normalized. 
 
4.1.2.3 Optimization of Affinity Wash Conditions 
Manipulation of wash conditions can be useful in altering interactions between protein 
species. In this way, simply changing the wash conditions has the potential to significantly increase 
the purity level of elution products (Bornhorst and Falke, 2000). A more effective wash buffer 
composition may provide the added benefit of no longer requiring the use of a cation exchange 
column first to disrupt protein-protein interactions. Although the PuriA protocol had been 
successfully removing some of the bacterial contaminants, its effectiveness was below optimal. It 
was speculated that using the affinity column, in combination with a selective wash buffer, before 
the ion exchange column could increase protein yield. The increase in yield would be on account 
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of greater selectivity of the NiNTA column for protein binding. A series of small-scale experiments 
using NiNTA resin was performed to compare wash buffers with different components 
hypothesized to disrupt protein-protein interactions. The goal behind this series of experiments 
was to obtain a wash buffer that would be able to dislodge the persistent contaminants without 
disrupting GSK3b binding and thus would remove the necessity of the SP column before the 
NiNTA column. For this series of experiments, the standard wash buffer (lsNA1) was adjusted or 
built upon with various components that have properties to disrupt different types of protein-
protein interactions. The conditions investigated include; high salt concentration (500 mM), 
Tween20 (1%), Glycerol (20%), Low Salt (NaCl) (50 mM), Low pH (pH 6.3), No salt (0 mM), 
Ethanol (EtOH) (20%) and β-mercaptoethanol (bME) (10 mM). High salt has the advantage of 
reducing non-specific ionic interactions (Dumetz et al., 2007). Tween20 is a surfactant detergent 
which has the potential to prevent weaker non-specific interactions from occurring.  Glycerol 
stabilizes proteins in solution and also acts to cover hydrophobic patches reducing hydrophobic 
interactions (Chi et al., 2003; Farnum and Zukoski, 1999). Low salt and no salt buffers will provide 
a low ionic interaction environment which may help certain hydrophobic species release from their 
bound contaminants (Dumetz et al., 2007). Ethanol in the wash buffer has also been shown to 
decrease the amount and strength of non-specific hydrophobic interactions (Bornhorst and Falke, 
2000). bME reduces disulfide bonds and can potentially disturb protein complexes bound in this 
fashion. The low pH buffer was intended to disrupt the overall charge of all the proteins present in 
an attempt to disturb the protein-protein interactions.  
The 20% EtOH, No-salt (0 mM NaCl) and Low-pH (6.31) buffer washes were unable to 
dislodge Contaminant60 or Contaminant70. The High-Salt (500 mM NaCl) wash had the lowest 
retention of GSK3b compared to any of the other buffer compositions. Tween (1%), βME (10 
mM) and Glycerol (20%) were better able to dislodge Contaminant60 but were unable to dislodge 
Contaminant70. The Low-salt wash (50 mM NaCl) appeared to remove all of Contaminant60 and 
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Figure 4- 5: Controlled comparison of the various wash buffers on NiNTA resin.  
All pellets were from the same batch of cells. 10 g of cell pellets grown in 2xYT were resuspended in 15 mL of 
lsL1 buffer. Lysis was conducted via sonication (6 mins at 50% duty and output 5) and bound to 100 μL of NiNTA 
resin at 4°C for 40min. The resin was then washed with 2.5 mL of each respective buffer. The resin was eluted 
with 125 μL of ssNB1. Elution fractions (E1 and E3) and wash fraction (W) were run on a 12% SDS gel to 
identify the effectiveness of each wash buffer. ImageJ analysis of band intensity for GSK3β (A1), Contaminant60 
(A2) and Contaminant70 (A3) was compared between conditions.  
most of Contaminant70. However, the majority of the experiments were analyzed using a precast 
stain-free gel from BioRad (Mini-Protean TGX Stain-Free Gels). Even though Figure 4-5 showed 
a GSK3β band with no visible Contaminat60, subsequent analysis using an SDS gel visualized 
with Coomassie stain revealed that Contaminant60 was still present after washing with low-salt 
buffer. The Mini-Protean TGX Stain-Free gels contain a trihalo compound which reacts with 
tryptophan in the presence of UV light to produce a fluorescent signal. This fluorescence is what 
is detected and measured to generate the final gel image. This is in contrast to Coomassie staining 
which utilizes a dye that binds to proteins through ionic interactions between the dye and protein 
amine groups. It was concluded that the stain-free gels and their subsequent visualization process 
are not able to detect the contaminating band with the same ability as Coomassie staining. In 
retrospect, this conclusion may have led to a disproportionate emphasis within the initial 
observation that a low-salt buffer was able to dislodge Contaminant60 completely. Regardless, the 
low-salt wash was still noted as the most efficient of the buffer compositions in its ability to 
dislodge a good majority of the protein contaminants. Future purifications were conducted with an 
added wash step which contained a low-salt wash buffer (lsSPA2).  
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4.1.2.4 Column Reversal Protocol 
Building upon previous observations geared towards the sequential use of affinity and ion 
exchange columns, it was proposed that using the NiNTA column before the SP column (PuriB) 
could be more effective at retrieving higher quantities of GSK3b. The theory follows that by using 
the NiNTA column first, more His tagged GSK3b could be retrieved and separated away from 
other proteins present in the lysate. Then this more concentrated fraction from the NiNTA column 
could be subjected to the same protein-disruption qualities provided by the SP column with less 
interference from other non-specifically binding proteins. This method should allow for a higher 
amount of GSK3b to be purified with fewer contaminants. This series of experiments sets out to 
examine the final elution fractions after a sample has gone through two sequential columns (SP 
first followed by NiNTA) compared to when the sample has gone through one single column 
(NiNTA with Low-salt wash).   
The results show that using a single NiNTA column complemented with an additional low-
salt wash produced a final elution fraction that was cleaner than when the SP column is used first. 
The NiNTA first fraction (Figure 4-6) clearly shows five distinct protein species; GSK3b (50kDa), 
Contaminant70, Contaminant60, Contaminant25 and another species located at 10kDa. The SP 
first fraction (Figure 4-6) clearly shows more than ten distinct protein species including the same 
main ones seen in the NiNTA first lane plus additional bands located at 125 kDa, 100kDa, 30kDa, 
and 15kDa. Concerning the effectiveness of the low-salt buffer, comparing the results from Figure 
4-6 to the results depicted in Figure 3-1 it can be stated that the use of the low-salt wash 
significantly reduces the proportion of Contaminant60 and Contaminant70 to GSK3b after NiNTA 
elution. Considering that the two-column approach using SP first not only requires more steps but 
also produces a final elution fraction with a higher proportion of unwanted protein species, it was 
concluded that using NiNTA first with a low-salt wash was the superior method for purification 
of GSK3b.  
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Figure 4- 6: Comparison of final elution fractions between SP column first and NINTA column alone.  
12% SDS gels depicting the final elution fraction after a two-column purification (either 1 mL NiNTA column or 
5 mL SP-FF column). 10 g cell pellets of cells grown in 2xYT were resuspended in 15mL of lsL3 and lysed with 
cell disruption (three rounds using 25 PSI). Lysed cells were spun down at 40,000 RPM for 40 mins. The 
supernatant was then applied to either a NiNTA column or an SP-FF column. While on the SP column the lysate 
was washed with 30 cv of lsSPA1 buffer and eluted with 10 cv of lsSPB1 buffer. While on the NiNTA column 
the lysate was washed with 20 cv of lsNA1 buffer, 10 cv lsNA2 buffer and eluted with 10 cv of lsNB1 buffer. 
Elutions occurred without gradient. The gel on the left shows GSK3b in the NiNTA elution when the lysate was 
run over an SP column first. The gel on the right shows GSK3b after a single column NiNTA purification utilizing 
the low-salt wash (lsNA2). 
4.1.2.5 SP Column with Low-salt Wash 
The elution fractions from the NiNTA column (Figure 4-6) were then subjected to ion-
exchange chromatography. The chromatogram results from the SP gradient elution showed 
overlapping peaks (Figure 4-7) within the elution fractions. It was hypothesized that these 
overlapping peaks were two distinct species eluting from the column at separate times. 
Corresponding gel analysis of the contents of the fractions showed the presence of Contaminant10 
eluting with GSK3b in the second fraction but not the others (Figure 4-8). It was postulated that a 
wash buffer containing a lower concentration of salt might be useful in eluting or dislodging 
Contaminant10 or the entire GSK3b-Contaminant10 complex apart from GSK3b alone. It was in 
turn, investigated if a Low-salt wash for the ion exchange column could potentially increase the 
overall product purity level and remove Contaminant10 entirely. The wash buffer (lsSPA1) used 
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for the ion exchange column contains no salt (0 mM NaCl), elution is accomplished with lsSPB1 
which contains a 1 M NaCl concentration. The change in buffer composition from low salt to high 
salt is how proteins are eluted. Proteins that bind less tightly to the resin (i.e., less positive charge) 
will elute at a lower concentration of salt and vice versa. The rationale behind using a Low-salt 
wash for the cation exchange column was an attempt to determine if the Contaminant10 binds less 
tightly to the resin and if so if it can be eluted separately from GSK3b with a buffer containing 50 
mM NaCl.  
  
Figure 4- 7: Chromatogram of Flow Through, Wash and Elution phases of an ion exchange column.  
Chromatogram shows the purification of 10 g cell pellet grown in 2xYT using Ind1 over 10 mL SP-FF column. 
The measured response is in mAu. Blue line depicts UV response. Green line is the concentration of elution 
buffer. Two peaks of interest indicated with arrows.  
The use of a buffer containing 50 mM NaCl to wash the cation exchange column proved to 
be ineffective (Figure 4-8). Contaminant10 remained present in the elution fraction after washing 
with a Low-salt buffer (indicated with the box in Figure-4-8). In addition to the persistence of 
this contaminating species, the Low-salt buffer decreased GSK3b’s ability to be retained on the 
column resulting in a lower overall yield of the desired product. The Low-salt wash did not 
influence the retention of Contaminant60 either. Since 50 mM of NaCl in the wash buffer is  
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Figure 4- 8: Comparison of the wash and elution fractions between regular wash and a low salt wash.  
12% SDS gel depicting the final elution fraction after a two-column purification. 10 g cell pellets of cells grown 
in 2xYT were resuspended in 15 mL of lsL3 and lysed with cell disruption (3 rounds of 25 PSI). Lysed cells were 
spun down at 40,000 RPM for 40 mins then purified according to PuriB. The Regular Wash gel depicts a standard 
elution series when the SP column is washed with a buffer containing no salt (lsSPA1). Low Salt Wash depicts 
an elution series where the SP column is washed with a buffer containing 50 mM NaCl (lsSPA2). 
enough to begin the elution process of GSK3b and fails at removing the lower contaminating 
bands, further investigation into the potential use of a Low-salt buffer for this column was not 
pursued. A gradient elution was not attempted since Contaminant25 is consistently seen in the 
second elution fraction and is interpreted as being more strongly bound than the species in the first 
elution fraction, therefore, it was predicted that GSK3b might be lost in too great of an amount to 
justify using a gradient elution.   
4.1.2.6 Anion Exchange Column for Binding of Contaminant60 
 Mass spectrometry was used by another member within the lab to determine that the 
persistent Contaminant60 is the common bacterial chaperone GroEL. GroEL is a 60 kDa folding 
chaperone found in many bacterial cell lines that are utilized for protein overexpression. It works 
in conjuncture with a 10 kDa folding partner termed GroES and requires ATP and Mg2+ to ensure 
the proper folding of native proteins (Hayer-Hartl et al., 2016; Lin and Rye, 2006). The isoelectric 
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point for GroEL was determined from the literature to be 4.5. The isoelectric point for GSK3b is 
8.9. The pH of the buffer used for all column chromatography experiments is 7.2. In these 
conditions, GSK3b should have an overall net positive charge and GroEL should have an overall 
net negative charge. Anion exchange resin is coated with positively charged groups which serve 
to bind negatively charged species in contrast to the reverse scenario for cation exchange resin. 
Considering the fact that the two proteins have opposite overall charges but still purify together 
with the cation exchange column, it is reasonable to assume that the two proteins are in complex 
together despite having very different isoelectric points. Therefore, the rationale behind this series 
of experiments attempted to use the positively charged anion exchange resin to determine if it was 
more useful in disrupting the GSK3b-GroEL complex than the cation exchange resin.  
 
Figure 4- 9: Results of the HiTrapQ column to dislodge contaminants.  
20 g cell pellets of cells grown in 2xYT and induced via Ind1 were resuspended in 30 mL of lysis buffer lsL5 and 
lysed via cell disruption (2 rounds at 25 PSI). Lysed cells were spun down at 40,000 RPM for 40 mins. The lysate 
was applied to 2 mL NiNTA column. The bound lysate was washed with 40 cv of the lsNA1 buffer, 10 cv of 
lsNA2 buffer and eluted with 10 cv of lsLB1 buffer without a gradient. First two elution fractions are depicted 
(A). The elution fractions were pooled then applied to a 1mL HiTrapQ column where they were washed with 40 
cv of lsSPA1 buffer and eluted with 10 cv of the lsSPB1 buffer. The Flow-Through, Wash, and Elution fractions 
from the Hi-TrapQ column are depicted on the right (B). 
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 In this series of experiments the lysate containing GSK3b was first applied to the NiNTA 
column then pooled and applied to the HiTrapQ column along with the protocol outlined in PuriB. 
If the anion exchange resin were able to disrupt the GSK3b-GroEL complex, then GSK3b would 
have been present in the Flow Through or Wash fractions as it would not have bound to the resin 
on its own in its inherent positively charged state. However, Figure 4-9 B shows GSK3b eluting 
in the elution fraction along with GroEL (Contaminant60) and Contaminant70 in the same fashion 
that was seen when the cation exchange column was used. Even though GSK3b did not wash 
through the column as expected and instead came off during the elution, ImageJ analysis of the 
band intensity in the HiTrapQ elution indicates that the overall amount of GSK3b is less than the 
overall amount of GSK3b in the elution fraction after NiNTA. This indicates additional protein 
loss at some step during this process that is not commonly seen when the cation exchange column 
is used. This observations adds further evidence against supplementing the HiTrapQ column in 
place of the SP-FF column. There was a possibility that some GSK3b was dislodged from the 
complex as intended and remained in the wash fraction at a concentration too dilute to detect on a 
gel which might have served to explain the lower GSK3b yield in the elution fraction. Additional 
experiments conducted further processing and examination of the wash and flow through fractions 
were able to confirm that there was no GSK3b present in either fraction (results not shown). This 
series of experiments determined that the use of an anion exchange column in place of a cation 
exchange column is ineffective at separating GSK3b from GroEL in any greater capacity than the 
SP cation exchange column.  
4.1.3 Gel Filtration Optimization 
4.1.3.1 Gel Filtration without Prior TEV Cleavage 
Objective 3 required His-GSK3b for compatible use with a Ni+ coated SPR chip to 
accomplish the binding studies. His-GSK3b obtained from the NiNTA column after purification 
via PuriB was of adequate concentration but of low purity. It was hypothesized that applying the 
NiNTA elution fraction to a size exclusion column (Gel Filtration) might serve to increase the 
purity level of GSK3b. Considering that the size exclusion column separates protein species based 
on the size of their complexes in solution, then any proteins in the solution that was in an active 
complex would elute together as one distinctive peak. However, since the SDS gel is denaturing, 
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the sampled peak would present as multiple bands representing the number of proteins in a 
complex. In this manner, any species of GSK3b in the solution that elute at 15 mL, the 
corresponding volume of proteins 50 kDa in size for the Superdex 200 10/300 GL, should be 
relatively pure and any GSK3b species eluting elsewhere in the volume could be assumed to be in 
complex with other proteins in solution.   
 
Figure 4- 10: Gel filtration elution’s and chromatogram showing separation of GSK3β species. 
10 g cell pellet of cells grown in 2xYT were resuspended in 15 mL of lsL3. Cells were lysed via cell disruption 
(25 PSIx2) and spun down at 40,000 RPM for 60 mins. The lysate was applied to a 1 mL NiNTA column (washed 
with 20cv of lsNA1 buffer followed by 10 cv of lsNA2 buffer and eluted with 10 cv of lsNB1 buffer. The elution 
fractions were then applied to a 5 mL SP-FF column (washed with 30cv of lsSPA1 buffer and eluted with 10cv 
of lsSPB1 buffer) as outlined in PuriB. SP elutions were pooled and concentrated down to 1.1mg/mL. 450 μL of 
the concentrated protein was injected onto the Superdex300 Gel Filtration column and eluted with lsGF1 over 1.5 
cv at 0.5 mL/min. The resulting 12% SDS gel (A) shows the array of protein species correlated to where they 
eluted on the gel filtration chromatogram (B). 
Results from this series of experiments were able to show that GSK3b could be separated 
into groups relating to what other protein species were complex with it (Figure 4-10). The earlier 
fractions (A8-A12) show GSK3b is eluting with Contaminant60 in the void volume segment. For 
this specific column, the void volume is contained within the peak from 6-13 mL on the 
chromatogram which correlates to all fractions up to and including B6. The presence of these 
proteins within the void volume suggests that they are in an aggregated form as they passed through 
the column quicker than expected signifying their complexed size is larger than the SDS gel 
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indicates in their individual sizes to be. The middle fractions (B7-B9) contained GSK3b and a 
small amount of Contaminant70. The later fractions (B10-B12) contained the majority of GSK3b 
with Contaminant25 and Contaminant10. The very last fraction depicted on the gel (C2), shows 
the two lower contaminants eluting on their own. Fractions B10-B12 correlate with the volume on 
the chromatogram where monomeric GSK3b is anticipated to elute based on its size. Future 
attempts to replicate these results showed the same trend with GSK3b + Contaminant60 eluting 
first and GSK3b + Contaminant25 and Contaminant10 eluting last with each fraction in the middle 
containing a small amount of Contaminant70 and none of the fractions with GSK3b on its own 
(results not shown).  Conclusions from these experiments determined that low levels His-GSK3b 
with a purity above 80% can be obtained using this method. Despite the small amount of protein 
obtained, the product is still usable for downstream SPR and enzyme activity studies.  
4.1.3.2 Replace HEPES Buffer with MES Based Buffer 
The paper by Aoki et al. 2000, that this protocol was initially adapted from utilizes an MES 
buffer (pH 6.5) containing a lower salt concentration (175 mM) for the gel filtration stage. It was 
theorized that the conditions created by this buffer could be useful in encouraging Contaminant25 
and Contaminant10 to separate from GSK3b. The conditions of the buffer might also have the 
ability to disrupt the interactions between GSK3b and Contaminant60/Contaminant70.  The MES 
buffer runs at a pH of 6.5 compared with the HEPES buffer which runs at a pH of 7.4. In the case 
of GSK3b with a pI of 8.1, the lower pH of the MES buffer will increase the overall surface charge 
of the protein which could potentially disrupt some protein-protein interactions. The rationale for 
the lower salt concentration most likely is related to the author's optimal conditions determined for 
their construct. Most notably the desire to attempt purification using this buffer was to replicate 
the success of the authors who published the protocol. 
The results from this experiment can be directly compared to the results depicted in Figure 
4-10 as the initial preparation of the cells/lysate through the first two columns was shared. The 
final elution product after NiNTA was concentrated down to 1 mL at 1.1 mg/mL. 450 μL of this 
product was applied to the gel filtration column run with lsGF1 (Figure 4-10) while the remaining 
450 μL of this same product was applied to the gel filtration column and run with lsGF2 (Figure 
4-11). The results from this experiment illustrate that our construct of GSK3b appears to be 
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unstable in the MES buffer with 175 mM of NaCl (lsGF2) as the resulting gel shows no visible 
GSK3b bands (Figure 4-11). Contaminant60 can still be identified eluting in the void volume 
(Fraction A12) along with Contaminant10 which can still be detected eluting in the later fractions 
(Fraction B12). The chromatogram of the purification conducted with the MES buffer (Figure 4-
11 / B) showed peaks that were smaller in height and area when compared to the sample 
counterpart conducted using HEPES buffer (Figure 4-10 / B). It can also be noted that the peak 
array for the MES buffer chromatogram consists of 5 distinct peaks, but only the first two within 
the predicted GSK3b elution range is depicted on the SDS gel. Extensive cleaning of the column 
with NaOH directly after this experiment showed large peaks eluting suggesting the possibility 
that aggregated protein had become stuck on the column during the purification process. 
Conclusions from this series of experiments imply that the use of MES buffer with a low salt 
concentration may contribute to the aggregation of this particular construct of GSK3b.  
 
 
Figure 4- 11: Gel filtration elution’s and chromatogram results with MES based buffer in place of a HEPES 
buffer.  
10 g cell pellet of cells grown in 2xYT were resuspended in 15 mL of lsL3. Cells were lysed via cell disruption 
(25 PSIx2) and spun down at 40,000 RPM for 60 mins. The lysate was applied to a 1 mL NiNTA column (washed 
with 20 cv of lsNA1 buffer followed by 10 cv of lsNA2 buffer and eluted with 10 cv of lsNB1 buffer. The elution 
fractions were then applied to a 5 mL SP-FF column (washed with 30 cv of lsSPA1 buffer and eluted with 10 cv 
of lsSPB1 buffer) as outlined in PuriB. SP elutions were pooled and concentrated down to 1.1 mg/mL. 450 μL of 
the concentrated protein was injected onto the Superdex300 Gel Filtration column and eluted with lsGF2 over 1.5 
column volumes at 0.5 mL/min. The resulting 12% SDS gel (A) shows the array of protein species correlated to 
where they eluted on the gel filtration chromatogram (B). 
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4.1.3.3 Addition of EDTA to Gel Filtration Buffer 
In order to address the GSK3b/Contaminant60 and 
GSK3b/Contaminant25/Contaminant10 bands observed in the early and late fractions of gel 
filtration (Figure 4-10), it was theorized that the addition of EDTA to the gel filtration buffer could 
potentially decrease GSK3b aggregation (A.Levi et al., 1974). NiNTA columns can leech Ni+ ions 
into solution causing the Histidine tags present on the recombinant proteins to cluster around these 
leeched ions leading to increased aggregation. EDTA is useful to combat this phenomenon since 
it is a chemical capable of chelating metal ions including Ni+. The addition of EDTA could 
potentially reduce the effect of the Ni+ ions which may lead to a decreased amount of protein 
aggregation. This series of experiments attempted to determine if the addition of EDTA to the gel 
filtration buffer could produce a fraction of GSK3b free from other protein contaminants.  
 
Figure 4- 12: Gel filtration elution’s and chromatogram results with EDTA added to the running buffer.  
10 g cell pellet of cells grown in 2xYT were resuspended in 15 mL of lsL3. Cells were lysed via cell disruption 
and spun down at 40,000 RPM for 60 mins. The lysate was applied to a 1 mL NiNTA column (washed with 20 
cv of lsNA1 buffer followed by 10 cv of lsNA2 buffer and eluted with 10 cv of lsNB1 buffer. The elution fractions 
were then applied to a 5 mL SP-FF column (washed with 25 cv of lsSPA1 buffer and eluted with 15 cv of the 
lsSPB1 buffer. SP elutions were pooled and concentrated down to 0.96 mg/mL. 450 μL of the concentrated protein 
was injected onto the Superdex 200 10/300 GL gel filtration column and run with lsGF1. The later elution 
fractions from this gel filtration containing GSK3b and Contaminant25/Contaminant10 (A) were pooled and run 
over a gel filtration column using lsGF3 (B). The chromatogram for the gel filtration using lsGF3 shows two 
distinct peaks (C). 
The results from this series of experiments aimed to show the potential of EDTA to separate 
Contaminant25 and Contaminant10 that elute with GSK3b in the later fractions of gel filtration 
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(Figure 4-12 / A). The resulting chromatogram (Figure 4-12 / C) displayed two distinct peaks at 
14.5 mL and 20 mL respectively. The peak at 14.5 mL would usually indicate monomeric GSK3b 
in solution; however, the corresponding SDS gel (Figure 4-12 / B) showed little to no GSK3b 
protein in any of the fractions. The only protein easily visible on the gel is Contaminant10 which, 
despite its small size, elutes at 14.5 mL. Since no actual GSK3b bands can be seen on the gel from 
this experiment, it can be inferred that the addition of EDTA to the gel filtration buffer may not be 
helpful in separating the lower band contaminants from GSK3b and that the addition of EDTA 
may be detrimental to protein yield. It is possible that this construct of GSK3b does not respond 
well to buffer changes which do not occur gradually and in response to this the protein is 
aggregating and remaining stuck to the column. However, further investigation into this theory 
using a more concentrated protein sample would be valuable in order to draw any firm conclusions.  
 
4.2 Discussion 
4.2.1 Cell Lysis Protocols 
The results described above demonstrate that the overuse of sonication is detrimental to the 
process of collecting large amounts of protein in its folded form. It is highly probable that this is 
due to over sonication causing aggregation of the protein products (Stathopulos et al., 2008). 
Sonication uses sound waves, and a side effect of this increased friction is the production of heat. 
Certain protein species, including GSK3b, are sensitive to increased temperatures and tend to 
denature or aggregate as a result. Even though the sonication process is done with the cells 
physically resting on ice, it still has the potential to create heat within the system since the cells 
closest to the probe will be more directly affected than the cells lining the outside of the tube which 
is closest to the ice. The process of sonication creates a force which pushes the solution down and 
out. This creates a system that primarily serves to mix itself which should act to keep the cells 
from overheating but is not always efficient. It is possible that there was not a long enough break 
in between bursts of sound waves. A more extended rest would have given the energy particles 
created more time to disperse before incurring additional rounds of sonication. It is also possible 
that the force of sonication can sometimes shear proteins or cause them to break apart. A clear 
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indication for aggregation is the loss of protein product identified by a decrease in band intensity 
via SDS analysis and Coomassie staining. A sign of protein sheering or degradation is a rise in the 
number of protein species present in solution. Both of these conditions can be observed in Figure 
4-2 / A and were described above.  
Cell disruption is a process which utilizes high pressure to break cells open. Cell disruption 
works by first compressing cells through a small orifice at high velocity, followed by their rapid 
expansion which disrupts the bacterial cell membrane (Burden, 2008). The process can be more 
effective at keeping proteins folded and in a soluble state compared to sonication. In addition to 
being a gentler process, it is also thought to be more desirable as the entire process occurs in a 
temperature-controlled unit which resists overheating more effectively than placing cells on ice. 
The pressure (PSI) used to act on the cells can be adjusted to suit different bacteria and can even 
be used to selectively disrupt for DNA, cytoplasmic protein, inclusion bodies, and membrane 
proteins. Like with the process of sonication, overuse of cell disruption can also result in the 
breakdown of protein products. Within the confines of the work conducted in this thesis, it was 
determined that two or three rounds at 25 PSI was suitable for high levels of protein retrieval and 
that this level of cell disruption was more beneficial than sonication alone.  
There are additional methods for cell lysis that have yet to be attempted for GSK3b grown 
in E. coli at a large scale. These methods include thermal lysis, manual grinding, lysozyme, use of 
a bead mill, and chemical cell disruption (Burden, 2008). Thermal lysis is a method where cells 
are frozen and thawed repeatedly, this process induces the formation of ice crystals which disrupt 
the cell membrane and in doing so, breaks cells open. Freeze-thaw can potentially be less abrasive 
on cell components, but it requires more time and can lead to possible protein degradation from 
the continual heating and cooling process (Johnson and Hecht Michael, 1994). Manual grinding is 
the use of mortar and pestle to physically grind the cells into dust disrupting the cell membrane in 
a physical way (Johnson and Hecht Michael, 1994). Manual grinding can be useful in that it is 
inexpensive and straightforward, but it is more difficult to control or regulate and carries a higher 
risk for cross-contamination. Lysozyme is an enzyme which reacts with peptidoglycan and breaks 
the glyosidic bonds of polysaccharides (Valerie A. Proctor et al., 1988). It is advantageous in that 
it is specific for bacterial cell lysis but can be problematic with sensitive proteins as its use requires 
cells to be in a solution of pH 6-7 at 35 degrees C for a prolonged period. This temperature and 
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pH could be problematic for GSK3b. Bead mill is a process whereby cells in solution are agitated 
by small beads of glass, ceramic or steel which are mixed with the cells at high speeds (Burden, 
2008; Shrestha et al., 2012). This process is efficient in its guaranteed ability to lyse all cells in 
suspension, however because it disintegrates cell membranes downstream purification can become 
more difficult. Finally, chemical lysis is the use of alkaline solutions or detergents to lyse cell 
membranes (Burden, 2008). Although these solutions can be gentler on the cell membranes 
themselves, it becomes more challenging to maintain proteins in their native form in the presence 
of harsh detergents. An appropriate lysis method is essential to determine when working with a 
protein such as GSK3b which does not have a significant initial overexpression rate and tends to 
aggregate in non-optimal conditions. It is possible that cell disruption is the best method but further 
investigation into alternative methods might prove to be beneficial.  
4.2.2 Column Purification Protocols 
4.2.2.1 Cation Exchange Resin and Flow Rate Optimization 
Optimization of the resin beads was initially investigated as a potential solution for 
increasing the overall rate at which lysate could be processed. Faster processing allowed for the 
upscaling of purifications while simultaneously decreasing the potential degradation from 
prolonged exposure to enzymes in the lysate. It was determined that SP-FF resin was the best 
suited since it could run the lysate faster than SP-HP on account of the larger bead size. Larger 
bead sizes cause greater gaps between beads which in turn results in less resistance to higher flow 
rates. Even though the SP-XL column also consisted of the same sized beads as SP-FF, it was not 
as favorable as it appeared to retrieve less GSK3b. Nevertheless, it was interesting that the SP-XL 
column showed an elution fraction which seemed to contain only Contaminant60 and 
Contaminant70 (Figure 4-4, SP-XL, Elution 1). The SP-XL resin contains the same size beads as 
SP-FF resin, but it also has long extender regions. These extender regions are long chains of 
dextran coupled to the 6% highly cross-linked agarose matrix. Their intended purpose is to increase 
the surface area of the SP charged groups to the lysate which in turn would increase the loading 
capacity. Knowing this information, it is possible that the extender regions might play a role in 
physically dislodging Contaminant60 and Contaminant70 from GSK3b. Even more interesting is 
that the contaminants are prone to eluting first a whole fraction before GSK3b elutes. Perhaps the 
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contaminants are resting on the extender regions and are less tightly associated might explain why 
they are first to come off. Despite this useful characteristic, the resin was unable to retain high 
levels of GSK3b and as such was not pursued. However, it is possible that the two columns could 
somehow be used in tandem to utilize the retention capability of SP-FF with the contaminant 
dislodging capability of SP-XL. Continued investigations into that line of thinking might be useful 
in the future.  
4.2.2.2 Affinity Wash Buffer with Column Order Reversal  
 To further examine the desire to rid the protein preparation of Contaminant60 and 
Contaminant70, affinity column wash buffers with varying properties were explored. Proteins in 
solution may interact with each other on account of electrostatic and van der Waals forces, 
hydration effects, disulfide bonds, salt bridging and ion binding (Dumetz et al., 2007). The main 
components in each of the wash buffers tested include; high salt concentration (500 mM), Tween20 
(1%), Glycerol (20%), Low Salt (50 mM), Low pH (pH 6.3), No salt (0 mM), Ethanol (20%) and 
BME (10 mM). The purpose of testing different wash buffer components were described in detail 
within the results section.   
Of all the different wash varieties tested the low salt wash appeared to be the most useful. 
Even though the low salt wash was unable to dislodge 100% of the protein contaminants, it was 
still successful in its ability to dislodge a majority of the contaminants. The results from this 
strongly suggest that the majority of the contaminants seen after NiNTA purification are associated 
with GSK3b in some way. The logical assumption is that these contaminants are either in a 
complex or aggregated. It remains difficult to distinguish if all the contaminants are bound in this 
manner or if only a subset are. It is likely that while some of the proteins can be washed off with 
the low salt wash, the others may remain bound to GSK3b by alternative means and thus be 
unaffected by the low salt wash. The investigation of other component washes to be used in 
combination with a low salt wash might increase the amount of Contaminant60 and 
Contaminant70 being dislodged from GSK3b or the column. The initial intention to investigate 
wash buffers for the NiNTA affinity column originally stemmed from the desire to remove the 
need for the lysate to pass over the ion exchange column before being introduced to the affinity 
column. The results here suggest that the use of an ion exchange step might still be the best way 
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to begin the process of purification as it seems to have the ability to dislodge the protein-protein 
interactions at a greater rate than relying on an affinity wash buffer alone. However, the low salt 
wash should be adapted into the NiNTA column purification step to increase the purity of the 
overall protein yield.   
 To further address the usefulness of the low salt wash for the NiNTA purification and the 
apparent requirement of an ion exchange step, a series of experiments was designed based upon 
the reversal of the previously established column order. This meant running the NiNTA column 
before the SP column with the overall goal being to purify GSK3b that still retains its His tag. The 
purity of the product after this step is much higher than when the columns are run in the opposite 
order. This is likely because more GSK3b is retained when the affinity column is used first since 
the attraction between the His tag and the NiNTA resin is more specific than the attraction between 
opposite charges in the cation exchange column. It is also possible that when the SP column was 
run first, it was becoming overloaded by the wide variety of protein species in the lysate and thus 
either failing to separate GSK3b effectively from its contaminants or merely failing to bind GSK3b 
all together. Overall it can be stated that the use of NiNTA before SP is more beneficial for 
retrieving higher yields of His tagged protein. However, this column reversal is not as useful for 
when the desired product is to be without its His tag. This is due to the incompatibility of the buffer 
components with downstream steps. For example, the next step after the first two columns is to 
incubate the eluted products with TEV protease. This is problematic when the SP column is second 
because TEV protease has low activity and tends to aggregate in the presence of high salt and the 
SP elutions are in a buffer containing 1 M NaCl. Attempts to cleave the tag with the protein in this 
buffer resulted in protein or enzyme precipitation. To fix the incompatibility issue would require 
diluting out the salt which runs the risk of GSK3b loss from being over-diluted. Alternatively, the 
protein preparation could undergo dialysis to reduce the salt. Lastly, the preparation could start 
with a greater amount of cell pellet to accommodate for the additional protein loss.  
4.2.2.3 SP Column with Low Salt Wash 
 A low salt wash for the cation exchange column was investigated after a notable indication 
of overlapping peaks was observed in the chromatogram (Figure 4-7). It was hypothesized that a 
low salt wash at this step could dislodge the Contaminant10 seen eluting with GSK3b if the two 
 58 
proteins were associated via electrostatic interactions. However, the use of a low salt wash for the 
cation exchange column proved to be ineffective. Ion exchange elution works with less specificity 
than affinity elution as it relies on the varying strength of different ionic interactions. Increasing 
the salt concentration in the wash buffer will provide additional ions to compete with binding to 
the column displacing the protein interactions already associated with the column. Since ions in 
solution non-specifically associate with ions on the column, it becomes increasingly difficult to 
use varying concentrations of salt to elute protein species selectively. This series of experiments 
serves to support this theory by showing that even a small amount of salt in the buffer is enough 
to dislodge GSK3b from the column in the wash fraction. Concerning the elution of 
Contaminant10 along with GSK3b in a distinct fraction strongly suggests that a small subset of 
GSK3b in solution is bound by Contaminant10 and this binding alters the surface charge of the 
complex thereby causing it to elute in a separate fraction. Further attempts to optimize the wash 
buffer for the SP cation exchange column would not be advised in order to minimize unnecessary 
GSK3b loss.  
4.2.2.4 Anion Exchange Column for Binding of 60kD contaminant 
 Anion exchange differs from cation exchange in that it contains positively charged resin 
beads instead of negatively charged resin beads. The experiment attempted to use a column of 
opposite charge to separate GSK3b from its contaminants based on their difference in surface 
charge. However, the use of the anion exchange column was overall ineffective at separating 
Contaminant60, suspected to be GroEL, from GSK3b. The ineffectiveness of this column was 
likely because the initial theory was developed based on the assumption that GSK3b and 
Contaminant60 were only co-purifying together and not complexed together. The results showed 
that GSK3b still eluted in the elution fraction despite its assumed positive surface charge. The 
results show that GSK3b and Contaminant60 will bind equally well to a negatively charged resin 
(cation exchange column) or a positively charged resin (anion exchange column) despite GSK3b 
having a surface charge opposite that of Contaminant60 (GroEL) in a buffer of pH 7.4.  From these 
results, it could be suggested that GSK3b might possibly be in a complex with Contaminant60, 
and that the complex has an overall surface charge that binds equally well to anion resin as cation 
resin. GroEL works by forming a barrel-like structure that surrounds its target protein and uses the 
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hydrolysis of ATP to complete the reaction that releases the target from the barrel in its fully folded 
state (Lin and Rye, 2006). If the two are purifying as one complex then that fraction of retrieved 
GSK3b is not likely to be functional in an unobstructed and active state. In order to increase 
GSK3b purity and activity, it would be beneficial to design a protocol that would specifically 
dislodge the GroEL from GSK3b. Some suggestions for future researchers to attempt include the 
use of a wash buffer containing ATP and Mg2+. Both ATP and Mg2+ are necessary for the completion 
of the GroEL folding and release reaction (Hayer-Hartl et al., 2016; Lin and Rye, 2006). The 
addition of these components to subsequent wash buffers could potentially encourage the GroEL 
attached to GSK3b to complete its reaction, release the protein and ultimately yield a higher 
portion of folded active GSK3β for downstream use.  
4.2.2.5 Gel Filtration Optimization without Prior TEV Cleavage 
 The remainder of the purification work focused primarily on optimizing the process of gel 
filtration so that it could be used to produce fractions of His-GSK3b with greater than 80% purity 
for downstream use in enzyme kinetic and activity assays. The positive aspect of the protocol is 
that small amounts of relatively pure His tagged protein can be obtained. This is beneficial for 
enzymatic studies which only require nanomolar amounts of protein for completing the analysis 
and where the presence of the His tag is useful instead of a hindrance. In contrast, the negative 
aspect of this protocol is that it fails to retrieve large amounts of protein at a concentration high 
enough to attempt structural analysis. However, it remains possible that the protocol could be 
further optimized to bring it to a point where enough protein could be purified for structural studies. 
Concerning structural studies, the presence of this His tag might be a hindrance as it is currently 
unknown if the tag could potentially interfere with crystal formation. Despite its inadequacy for 
use in purifying the protein for structural analysis, the gel filtration after two-column protocol has 
the potential to be optimized further to increase the amount of retrievable His-GSK3b.  
The published paper, from which this protocol was initially adopted, utilized an MES 
buffer with a lower pH in place of HEPES (Aoki et al., 2000). However, attempts to replicate the 
experiment using the buffer proved detrimental to protein retrieval as demonstrated in Figure 4-
11. It can be hypothesized that the protein, in the presence of the MES buffer, was lost due to the 
low concentration of salt. The specific GSK3b construct utilized in this thesis prefers to be in a 
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solution containing 300 mM – 500 mM NaCl and it is possible that the low concentration of salt 
caused some degree of aggregation. Future attempts at optimization could include the use of the 
MES buffer with a salt concentration between 300-500 mM. Another possibility is that the 
construct did not favor the slightly acidic environment with the pH being below 7.0. Some 
recombinant proteins are intolerant of acidic environments and are prone to denaturation. 
Additionally, the protonation state of the Histidine tag is altered at or below a pH level of 6.5. The 
change in protonation could potentially cause aggregation of the Histidine tagged product. The 
most likely explanation for the resulting protein loss is that the combination of the two conditions 
(low pH and low salt) caused the protein to aggregate during this experimental. After the 
preparation was completed an extensive clean on the gel filtration column was conducted, and 
large peaks were observed eluting from the column during reverse flow cleaning. This observation 
confirms that the protein was more than likely aggerated and becoming stuck on the column at or 
above the filter. This scenario explains why no protein was observed in the actual elution, but a 
clear peak was observed when the column was run using reverse flow. A more comprehensive pH 
optimization series of experiments would be beneficial in the future to address if the issue indeed 
is related to the change in pH or the low salt concentration. For this thesis, no subsequent work 
utilized MES buffer or low salt running buffers. 
 
Regarding the potential use of EDTA in the gel filtration buffer to act as a chelator of any 
leeched Ni+ ions, the results were mostly negative. The lack of GSK3b bands on the SDS gel 
strongly suggests that the protein became aggregated, and similar to the MES buffer results, 
remained stuck at or above the filter of the gel filtration column. Since EDTA works to chelate 
metal ions, one assumption is that the Histidine tags present on the proteins were even more 
strongly drawn together due to the concentrated collection of Ni+ ions and formed aggregated 
clumps as a result. The only prominent bands that had an intensity bright enough to be visible on 
the SDS gel was Contaminant10 which eluted at the 15 mL mark. This observation is similar to 
the results seen in other experiments where the contaminants are eluting in the same region without 
the visible presence of GSK3b. It does not follow that the smaller proteins would elute at the same 
volume as a protein five times its size unless it is an entirely different protein species that forms 
an oligomer in solution. It could also be possible that this is a truncation product of GSK3b forming 
an aggregate or oligomer. This would explain why it is eluting off the gel filtration column as if 
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its size was 50 kDa but running on an SDS gel as if its size was 10 kDa. The main argument against 
this suggestion is that the presence of TCEP in the buffer should cause any dimers/oligomers to 
take their monomeric form if they were held together by disulfide bonds. However, it is possible 
that the oligomers are forming due to other forces or favorable interactions. Investigations into the 
identity of Contaminant10 are essential for the purification process as the band appears to associate 
tightly with GSK3b through the many column steps and even elutes at the same volume during gel 
filtration. Alternate studies, including Mass Spectrometry, could focus on detecting the identity of 
this band so that more effective and targeted attempts to remove it could be explored.  
Any further work put forth to optimize gel filtration after a two-column purification without 
TEV cleavage of the His tag should include experimenting with reducing the speed of the gel 
filtration column. It is possible that by reducing the speed and allowing more time for the 
separation of protein species, the yield of pure protein could increase slightly higher. However, 
considering the three main peaks that consistently elute from the gel filtration column, it does not 
seem apparent that this protocol would ever serve to separate all of the GSK3b in solution from 
all other protein species. 
4.3 Summary 
 The purification of this construct is currently at a stage where it is useful at producing His 
tagged GSK3b at levels adequate for enzymatic characterization analysis such as ADP-GLO and 
SPR. However, the purification protocol has a few significant hurdles concerning its ability to 
produce cleaved GSK3b at levels useful for crystallization and other characterization studies 
requiring concentrated and highly pure protein. The overall purification protocol was able to utilize 
10 g of cell pellets lysed using a cell disruptor (two rounds at 25 PSI) bound first to a NiNTA 
column and washed with a buffer containing 50 mM NaCl before being applied to an ion exchange 
column. The elutions from the ion exchange column were concentrated down an applied to a gel 
filtration column where approximately 0.2 mg of protein at a purity level of 80% could be obtained. 
One of the most prominent issues experienced throughout purification is the presence of the 
Contaminant60, Contaminant70, Contaminant25, and Contaminant10. These contaminants appear 
to be in complexes with GSK3b. The gel filtration elution fractions show that not all of the GSK3b 
in solution are complexed with the same combination of contaminants and thus elute at different 
places accordingly. This could potentially suggest that these contaminants are becoming associated 
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with GSK3b at different stages of the overexpression or purification process. For example, it is 
possible that the GSK3b complexed with Contaminant60 seen eluting mostly in the void volume 
could be aggregated protein which formed as a result of overexpression and was purified in that 
form. It is conceivable that the GSK3b seen eluting with Contaminant25 and Contaminant10 later 
on in the elution phase is GSK3b which has become associated with these contaminants during the 
process of purification or even during the concentration stages where the protein is prepared for 
the gel filtration column. At this point, it is difficult to distinguish what complexed species 
emerged as a result of which stage. This ambiguity ultimately increases the difficulty in correcting 
the issue or removing the contaminants. Some suggestions were described above, and it can be 
stated that the purification protocol, albeit operational, requires more work in order to be of a 
desirable efficiency.  
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5.0 Objective 3: Investigation of the Inhibition Mechanism of DISC1-44mer 
Against GSK3b using Biochemical and Biophysical Approaches 
 
This chapter focuses on detailing the enzymatic relationships between GSK3b, a short 
fragment of DISC1 (DISC1-44mer) and a short fragment of FRAT (FRATtide). Both protein 
fragments are known to bind and inhibit GSK3b. It is known that FRAT binds to GSK3β at a site 
that overlaps with Axin binding and has been theorized to inhibit GSK3β activity towards select 
substrates (β-catenin) by obstructing Axins access to GSK3β (Bax et al., 2001; Fraser et al., 2002; 
Li, 1999). FRATs inhibition does not interfere with GSK3bs activity towards other substrates such 
as GSP2 (Culbert et al., 2001). The method of inhibition and the binding site for DISC1-44mer is 
still largely unknown. This chapter attempts to address the hypothesis and use surface plasmon 
resonance (SPR) studies in combination with enzyme inhibition kinetic studies (ADP-GLO) to 
determine if DISC1-44mer and FRATtide compete for the same binding site on GSK3b. This 
information will allow additional insight into how DISC1-44mer influences GSK3b inhibition and 
if this mechanism is similar to FRATs unique mechanism for GSK3b inhibition. For the series of 
SPR experiments, a double-tagged GSK3b product (His-GSK3b-His) was used in order to 
decrease the amount of protein drifting off the surface of the SPR chip. For the ADP-GLO 
experiments, a cleaved GSK3b product without a histidine tag (GSK3b) was used.  
5.1 SPR Results  
5.1.1 SPR Calculations 
For the SPR experiments the model chosen was a One to One model which assumes that 
one enzyme will interact with one molecule of analyte in solution. The equation used to calculate 
the fitted curve for a one to one model is; 
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dY/dt = (Ka * c – Kd)* Y ……………………………………………………………………..(5.1.1) 
where Y is the recorded signal (RU) observed after injection and c is the concentration of sample 
(M) in the bulk liquid. The equation described is a differential equation to which the measured 
data is fitted. The association rate (Ka) describes the rate at which the analyte-ligand complex is 
formed and is directly proportional to the concentration of analyte in solution ([A]) and the 
concentration of enzyme bound to the surface ([B]). The dissociation rate (Kd) describes the rate at 
which the analyte-ligand complex is being disassembled and is proportional to the concentration 
of the analyte-ligand complex ([AB]). The affinity constant (KD) represents the strength of the 
attraction between analyte and ligand at equilibrium. KD is accurately described as the 
concentration of analyte at half the enzyme concentration bound during equilibrium. The 
association and dissociation constants are described in more detail in Table 5-1. For the purposes 
of SRP studies, the concentration of analyte is measured in M and determined by the user. This 
concentration is essentially the concentration of analyte in solution and is maintained by the system 
throughout the duration of the injection. The enzyme-ligand complex (AB) is extrapolated from 
the data directly as the observed response (RU) following analyte injection. Lastly, the 
concentration of available unbound enzyme is determined by subtracting the observed response 
(RU) following the analyte injection from the Rmax. The Rmax is a measure of the maximum amount 
of enzyme bound to the surface and is calculated by multiplying the molecular weight (MW) of 
the analyte (g/mol) with the response observed from the initial capture of the enzyme (RU) and 
dividing the result by the MW of the enzyme (Table 5-2). In relation to the net rate equation in 
Table 5-1, the overall rate (d[AB]/dt) is (d[R]/dt) where R is the response observed after analyte 
injection. The [A] is the concentration of analyte in the injection, the [B] is taken from the Rmax – R 
and, the [AB] is R. The affinity kinetics described can be measured in one of two ways; as steady 
state parameters while the enzyme and analyte are at equilibrium or by measuring the on and off 
rates of the enzyme and calculating kd/ka. 
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Table 5- 1: Affinity and kinetics equations and units’ derivations.   
 
Table 5- 2: Rmax equation and units’ derivation.  
 
5.1.2 Binding Kinetics and Affinity of DISC1-44mer 
SPR technology was utilized to determine the binding kinetics and affinity constants for 
DISC1-44mer. Binding kinetics for mDISC1-44mer with hGSK3b had been previously 
determined in the literature, replication using hGSK3β with hDISC1-44mer was required to 
confirm binding and determine the kinetics. Kinetics and affinity measurements are essential to 
increase the understanding regarding the rate and strength of the interaction between the peptide 
and the protein.  
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Figure 5- 1: Affinity (Panel A) and Kinetics (Panel B) graphs of GSK3b binding associations with DISC1-
44mer.  
Individual binding replicates were conducted with the peptide at varying concentrations. His-GSK3b-His was 
captured on an SPR NINTA chip, and the peptide was analyzed at a 250 μL injection at 50 μL/min over 2 minutes 
followed by a 2-minute dissociation. All data points were collected separately with regeneration of the surface in-
between runs. All data was collectively pooled to fit into one affinity or kinetics curve represented above. From 
the data KD, Kd and Ka for DISC1-44mer were determined. Number of replicates is 1. Kinetics Chi2. =0.80. Affinity 
Chi2 = 1.69.  
 DISC1-44mer successfully shows binding to the His-GSK3b-His construct on an SPR chip 
at room temperature in the RB1 buffer (Figure 5-1). KD is a measure of affinity between the 
peptide and the enzyme, which for DISC1-44mer with GSK3b is 2.43 μM as determined by 
affinity calculations (Figure 5-1 / Panel A). DISC1-44mer has a slow on rate of 2.49e3 (M*s)-1 (Ka) 
and a slow off-rate of 3.41e-4 s-1 (Kd) (Figure 5-1 / Panel B). The data was collected as a result of 
separate full replicates meaning; His-GSK3b-His was captured on the SPR surface, a single 
concentration of DISC1-44mer was flown over the top, the kinetics were determined, and the 
surface was regenerated so that another capture of GSK3b could occur and be tested with a new 
concentration of DISC1-44mer. The data was collected in this fashion because DISC1-44mers 
slow off-rate made it difficult to ensure that all the ligand had been removed from the bound protein 
before an additional injection occurred. The individual data sets were compiled together using 
TraceDrawerTM software to yield the graphs and data in Figure 5-1. 
5.1.3 Binding Kinetics and Affinity of FRATtide 
 SPR technology was utilized to determine binding kinetics and affinity for FRATtide with 
His-GSK3b-His. Binding kinetics for this peptide fragment has not yet been determined in the 
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literature. This kinetic data was required to determine the ability of this peptide to bind to His-
GSK3b-His and to define the apparent strength of the interaction. Kinetics and affinity 
measurements are critical to increasing understanding of how the peptide fragment interacts with 
the double His tagged construct of GSK3b.  
 
Figure 5- 2: Affinity (Panel A) and kinetics (Panel B) graphs of GSK3b binding associations with 
FRATtide.  
Individual binding replicates were conducted with the peptide at varying concentrations. His-GSK3b-His was 
captured on an SPR NiNTA chip and peptide was analyzed at 250 μL injection at 50 μL/min over 2 minutes 
followed by a 2-minute dissociation. Some data points were obtained from the sequential injection of FRATtide 
at different concentrations without intermittent regeneration. Some data points were collected separately with 
regeneration of the surface in-between runs. From the data KD, Kd and Ka for FRATtide were determined. The 
fitted curve was determined using a one to one two State model to incorporate the conformational change of 
GSK3β that occurs as a result of FRATtide binding. Number of replicates = 1. Kinetics Chi2 = 8.3. Affinity Chi2 
= 6.32.  
FRATtide successfully shows binding with the His-GSK3b-His construct on an SPR chip 
at room temperature in the RB1 buffer (Figure 5-2). The KD, affinity measure between peptide 
and enzyme, for FRATtide with GSK3b, is 1.95 μM as determined by affinity calculations (Figure 
5-2 / Panel A). FRATtide has a relatively fast on rate of 2.4e4 (M*s)-1 (ka) and a moderately fast off 
rate of 1.06e-2 s-1 (Kd) (Figure 5-2 / Panel B). Due to its fast on and off rate, regeneration in between 
replicates, as was done for DISC1-44mer, was not necessary. However, in order to create a reliable 
replicate to the DISC1-44mer data, the FRATtide data was also compiled with replicates occurring 
over separate runs which included regeneration of the SPR surface in-between. This was conducted 
in the same manner as described for DISC1-44mer where His-GSK3b-His was captured on the 
SPR surface, a single concentration of FRATtide was flown over the top, the kinetics were 
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determined, and the surface was regenerated so that another capture could occur with a new 
concentration of FRATtide. This data was compiled with data collected from a continuous run 
which analyzed multiple concentrations of FRATtide sequentially flow over captured His-GSK3b-
His, without intermittent regeneration. It should be noted that the KD generated from this 
sequential run with no intermittent regeneration was 1.85 μM (data not shown) which is not 
considerably different from the KD calculated from the pooled data. As a result, data sets were 
merged using TraceDrawerTM software to yield the plots in Figure 5-2 so that they would be more 
comparable, in terms of methodology, to the DISC1-44mer data.  
5.1.4 Binding of DISC1-44mer and FRATtide  
 In an attempt to use SPR studies to determine if DISC1-44mer and FRATtide share the 
same binding site, combined and sequential binding studies were conducted. The initial 
investigation focused on the use of combined binding studies. The experiment aimed to determine 
the presence of a notable difference in KD from equilibrium when the analyte solution contained 
FRATtide and DISC1-44mer together as compared to when the analyte solution contained 
FRATtide or DISC1-44mer individually.  
 
Figure 5- 3:  Combined Binding Studies Data of DISC1-44mer, FRATtide and DISC1-44mer with 
FRATtide. 
Kinetics curve for His-GSK3b-His at a capture level of 2781 RU with 4 μM FRATtide with a signal response of 
28 uRIU (Panel A). Kinetics curve for His-GSK3b-His at a capture level of 2210 with 2.3 μM of DISC1-44mer 
with a signal response is 25 uRIU (Panel B). Kinetics curve for His-GSK3b-His at a capture level of 2781 RU 
with 2.3 μM of DISC1-44mer mixed with 4 μM of FRATtide and a signal response is 49 uRIU (Panel C). 
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 His-GSK3b-His was captured on to the SPR chip, and an analyte solution containing 4 μM 
of FRATtide was introduced (Figure 5-3 / Panel A). The results from this condition were compared 
to the results of His-GSK3b-His when 2.3 μM of DISC1-44mer was introduced (Figure 5-3 / Panel 
B). For both the FRATtide and DISC1-44mer conditions the capture level of His-GSK3b-His was 
above 2200 RU. For the FRATtide only condition, the Rmax was 162.46 RU. For the DISC1-44mer 
condition, the Rmax was 202.37 RU. The observed Rmax is much smaller than the theoretical Rmax for 
both single analyte conditions which indicates that the analyte concentration is not sufficient to 
occupy all of the available enzyme binding sites. The KD from the mixed condition is not useful 
in determining any insight into peptide binding as originally hypothesized. This is largely due to 
the fact that the DISC1-44mer condition does not conclusively reach saturation. As a result, the 
KD from the combined condition is not useful for any form of interpretation. Since the data from 
the combined binding study did not provide evidence into the possible presence of binding 
competition and is limited in its ability to produce steady state equilibrium for DISC1-44mer, 
further investigation using this method of analysis was not continued. However, the initial question 
regarding binding sites required added examination which included the sequential binding studies 
outlined below.  
The sequential method of investigation for this series of experiments encompassed 
capturing His-GSK3b-His on the SPR surface then injecting DISC1-44mer and FRATtide one 
after the other. The theory follows that if DISC1-44mer and FRATtide bind GSK3b at the same 
site, then the injection of DISC1-44mer should occupy all of the available binding sites leaving no 
opportunity for FRATtide to bind. In this scenario, the secondary injection of FRATtide should 
show no response on the resulting sensorgram.  
His-GSK3b-His was captured on the SPR surface, and DISC1-44mer at 4 μM was 
introduced, the response was approximately 11.1 RU (Figure 5-4 / Panel A). The SPR system 
automatically shifted to the sequential 4 μM FRATtide injection, and the response was 
approximately 13.1 RU (Figure 5-4 / Panel B). Dissociation over 3 minutes showed the response 
decrease by approximately 13 RU (Figure 5-4 / Panel C). The data suggest that both peptides are 
binding the enzyme at the same time since the expectation for Panel B in the event of a shared 
binding site was a flat line representing no association. The main issue regarding the data concerns 
 70 
 
Figure 5- 4 Initial attempts to use sequential binding studies to determine possible peptide competitive 
binding.  
His-GSK3b-His at a concentration of 3 μg/mL was captured at a level of 765 RU. RB buffer was run over the 
captured construct until the drift rate was 2.59 RU/min. A series of blanks was injected. DISC1-44mer peptide (4 
μM) dissolved in RB1 underwent a 25 μL injection at 50 μL/min over 2 minutes (Panel A). Immediately after, 
FRATtide (4 μM) dissolved in RB1 underwent a 250 μL injection at 50 μL/min over 2 minutes (Panel B). The 
construct was then allowed to undergo dissociation over 3 minutes (Panel C). 
the un-apparent saturation of His-GSK3b-His with DISC1-44mer before FRATtide injection 
(Figure 5-4 / Panel A Red Box). Since the experiment does not indicate if DISC1-44mer has 
occupied all of the available binding sites provided by the captured His-GSK3b-His, then it can 
be argued that FRATtide in Panel B is binding to any open or unclaimed sites.  
To address this issue, DISC1-44mer and GSK3b were incubated together at room 
temperature for 20 minutes, then the complex of DISC1-44mer/GSK3b was captured onto the SPR 
chip as a single unit. After capturing the complex, DISC1-44mer and FRATtide were injected 
sequentially in the same fashion described in the previous series of experiments. The theory behind 
this experimental design considers DISC1-44mers slow association rate and allows the peptide 
and enzyme sufficient time to form a complex in solution before capture. Since SPR methods 
includes the constant flow of solution over the chip and the analyte concentration is maintained by 
fixed injection rates, it is possible that DISC1-44mer does not have enough time to bind GSK3β 
before it is flown past. Allowing a period for incubation before capture serves to rectify this 
potential issue. The subsequent secondary injection and response of DISC1-44mer will serve to 
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illustrate if any DISC1-44mer open binding sites remain, and thereby confirm saturation, before 
the injection of FRATtide. 
 
Figure 5- 5: Sequential binding studies using incubation of protein and analyte prior to capture.  
His-GSK3b-His was incubated with 4 μM of the DISC1-44mer peptide in RB1 at room temperature for 20 
minutes then captured onto a NiNTA chip at a capture level of 553 RU. RB1 was passed over the surface until 
the drift was 2.23 RU/min. DISC1-44mer peptide (4 μM) dissolved in RB1 underwent a 250 μL injection at 50 
μL/min over 3 minutes and allowed to dissociate for 20 seconds (Panel A). Immediately after, FRATtide (4 μM) 
dissolved in RB1 underwent a 250 μL injection at 50 μL/min over 2 minutes with a response of 7.1 RU (Panel B) 
followed by a 2-minute dissociation (Panel C). The top graph represents the real-time response while the bottom 
graphs represent the data post-processing with TraceDrawer software.  
 His-GSK3b-His was allowed to complex with DISC1-44mer in solution at room 
temperature to ensure the association had time to occur. The His-GSK3b-His/DISC1-44mer 
complex was captured onto the SPR surface with a capture response of 553 RU and a Rmax of 29.59 
RU. Following the capture, DISC1-44mer at 4 μM was injected on top of the complex, and the 
resulting sensorgram showed no increase in response units (Figure 5-5 / Panel A). This flat line 
strongly suggests that all DISC1-44mer binding sites on GSK3b are saturated. Immediate injection 
of FRATtide at 4 μM following DISC1-44mer injection showed a clear response of approximately 
7.1 RU (Figure 5-5 / Panel B). Dissociation shows FRATtide coming off of the construct as 
expected (Figure 5-5 / Panel C). The response observed for FRATtide after the injection of DISC1-
 72 
44mer was comparable to the response observed when FRATtide was injected alone without the 
prior injection of DISC1-44mer (data not shown).  
 
5.2 ADP-GLO Results 
5.2.1 Determination of Optimal GSK3β concentration and Substrate Km  
 The determination of KM for GSP2 and ATP is a necessary step in the process of studying 
enzyme inhibition as it allows for the basic characterization of proper enzyme concentrations for 
planning competition studies. The KM of both substrates was determined via a luminescence 
response to an ATP dependent reaction assay (ADP-GLO). The ADP-GLO kit determines enzyme 
activity by first depleting unused ATP in a reaction then converting the ADP present in the reaction 
mixture back into ATP. Finally, the ATP undergoes an additional reaction which gives off a 
luminescent signal that is detected and interpreted directly as enzyme activity. Firstly, an optimal 
GSK3β concentration was determined via GSK3β enzyme activity assays. The ideal concentration 
was chosen from the middle of the produced curve. The concentration produced activity that gave 
an adequate reading without falling in the range of enzyme maximum activity (Figure 5-6). The 
experimental protocol for KM determination utilized the conventional technique of maintaining the 
concentration of one substrate while varying the concentration of the other substrate. Plotting the 
luminescent response against varying concentration allows the data to undergo Michaelis-Menten 
type analysis in order to determine the substrates apparent KM. GSP2 is a primed peptide fragment 
of the glycogen synthase protein which is a common GSK3b substrate.  
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Figure 5- 6: GSK3β activity assay.  
Two-fold series dilution of GSK3b from 3.125 nM to 200 nM was tested for luminescence readings when 
incubated with 9 μM GSP5, 15uM ATP and RxnB1 over one hour. Experiment was preliminary in nature to 
determine an adequate concentration of enzyme to use in order to obtain good luminescence readings in the 
20000-30000 range. Number of replicates is 1. R2= 0.71. Standard error = 6.57.  
 
Figure 5- 7: ADP-GLO studies to determine KM of ATP and GSP2 as substrates of GSK3b.  
Michaelis-Menton type kinetics was determined with varying concentrations of ATP while holding the 
concentration of GSP2 constant at a concentration of 35 μM n=2. R2=0.85. Standard error = 8.82 μM (Panel A). 
Michaelis-Menton type analysis was determined with varying concentrations of GSP2 while holding the 
concentration of ATP constant and at a concentration of 150 μM n= 1. R2=0.93. Standard error = 3.50 μM (Panel 
B).  
The activity assay (Figure 5-6) showed that 25 nM of GSK3b yielded an optimal 
luminescence reading between 20000 and 30000 units and falls in the middle of the curve in a 
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region that is apart from GSK3β’s maximum activity. Therefore, a 25 nM concentration of GSK3b 
was used for all subsequent experiments. The determined KM for ATP is 27.37 μM (Figure 5-7 / 
Panel A).  The determined KM for GSP2 is 14.3 μM (Figure 5-7 / Panel B). ATP has a comparatively 
higher KM compared to GSP2 (substrate) which indicates a moderately lower affinity for GSK3b. 
The determination of KM for ATP was conducted from replicate data. The determination of KM for 
GSP2 was conducted from a single set of data. The information collected from this series of 
experiments was useful in the design of future experiments. Therefore, the inhibition assays were 
conducted using 25 nM of GSK3b, and more than double the KM of ATP (27.37 μM) and half the 
KM of GSP2 (14.3 μM). 
5.2.2 Inhibition Activity Assay 
An inhibition activity assay was designed to ascertain if DISC1-44mer and FRATtide were 
competing for binding at the same site on GSK3b. From the literature, it is known that FRATtide 
binds to GSK3b without causing inhibition towards GSP2 in vitro but is able to cause inhibition 
in vivo. From lab experience, it is known that binding of DISC1-44mer to GSK3b does cause 
inhibition towards GSP2 in vitro. To ensure enough DISC1-44mer and FRATide were added to 
affect GSK3b activity, a concentration ~10x their corresponding KD as determined by SPR was 
used. This assay was conducted by examining enzyme activity of GSK3b (25 nM) in the presence 
of DISC1-44mer (25 μM), FRATtide (25 μM) and DISC1-44mer (25 μM) + FRATtide (25 μM) 
together. All experiments were conducted in the presence of GSP2 (9 μM) and ATP (100 μM). 
The hypothesis behind this experiment follows: if DISC1-44mer and FRATtide compete for the 
same binding site, then the result should show reduced activity in the condition where both peptides 
are incubated together. The theory follows that the GSK3b enzyme units bound to DISC1-44mer 
in solution will have no activity while the GSK3b units bound to FRATtide will retain activity. 
Therefore, the overall result for the mixed condition should show a partially reduced enzyme 
activity.  
 The experiment revealed that GSK3b activity in the presence of FRATtide was comparable 
to GSK3b alone in the absence of any peptides (Figure 5-8), which is expected as FRATtide does 
not inhibit GSK3b activity towards GSP2 in vitro. As was previously discussed in the introduction, 
FRAT acts to inhibit GSK3b by blocking the enzymes access to Axin and this effect is 
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predominantly seen in vivo towards the substrates β-catenin and Tau only (Culbert et al., 2001; 
Fraser et al., 2002; Li, 1999). The results demonstrated that GSK3b activity was inhibited almost 
entirely towards GSP2 in the presence of DISC1-44mer. GSK3b activity towards GSP2 in the 
presence of DISC1-44mer and FRATtide together revealed fully functional enzyme activity at a 
level comparable to GSK3b activity alone. The experiment was replicated to confirm the presence 
of the observed trend (results not shown).  
 
 
Figure 5- 8: ADP-GLO luminescent assay to compare GSK3b activity in the presence of peptides.  
Each condition contains GSK3b (25 nM), GSP2 (9 μM) and ATP (100 μM) in RxnB1. Each condition contains 
a combination of FRATtide (25 μM), DISC1-44mer (25 μM), both or none. The peptides were used at 
concentrations at least 10X the KD as determined from the SPR studies. All conditions were incubated at room 
temperature for 60 mins and samples were taken at 0, 5, 15, 30, 45 and 60 mins. Number of replicates is 1. R2 for 
GSK3β = 0.79. R2 for GSK3β and FRATtide = 0.89. R2 for GSK3β, FRATtide and DISC1-44mer = 0.93.  
5.3 Discussion 
5.3.1 Potential Model for DISC1-44mer and FRATtide Binding 
One potential model to explain the binding patterns of DISC1-44mer and FRATtide to 
GSK3b is outlined in Figure 5-9. Since the sequential SPR data strongly suggests that both peptides 
can bind simultaneously to GSK3b (Figure 5-5), it can be reasoned that their primary binding sites 
are not identical or overlapping in a manner that hinders either peptides binding ability. In contrast, 
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the kinetics data from the ADP-GLO study shows that incubating both peptides with GSK3b 
prevents the predominantly inhibitory effects of DISC1-44mer (Figure 5-8). The data taken 
together lends evidence for a model of DISC1-44mer and FRATtide binding where the binding 
sites are likely overlapping to some extent. Mao and colleges (2009) were able to show that of the 
44 amino acids present in the DISC1 peptide, only the 15 amino acids in the middle were required  
Top left is the crystal structure of FRATtide (orange) bound to GSK3b (yellow) which occurs in the C terminal region 
away from the active site. Scenarios A-C depicts a possible binding site for DISC1-44mer which would allow for the 
middle 15-mer region responsible for binding to be unobstructed. Scenario A shows FRATtide physically blocking 
the C terminal region of DISC1-44mer, Scenario B shows FRATtide physically blocking the N terminal region of 
DISC1-44mer and Scenario C shows FRATtide physically blocking both the C and N terminals of DISC1-44mer 
simultaneously. The top right crystal structure shows GSK3b alone (blue) overlayed with GSK3b bound to FRATtide 
(yellow/orange) and highlights the four major regions of GSK3b that change in response to FRATtide binding. 
Scenario D illustrates a possible binding mechanism of DISC1-44mer to GSK3b without FRATtide (blue). In this 
illustration, DISC1-44mer interacts with regions 2-4 on GSK3b but not region 1. GSK3b bound to both DISC144mer 
and FRATtide (yellow) shows how regions 1-4 shift and how these shifts might change the way DISC1-44mer 
interacts with GSK3b regions 1-4. GSK3b with FRATtide is from PDB file 1GNG (Yellow). GSK3b alone is from 
PDB file 1H8F.   
for binding (Figure 1-5 / Green and purple rectangle) (Mao et al., 2009). However, the 15-mer 
segment on its own was not sufficient to cause inhibition of GSK3b. Their findings reiterate that 
Figure 5- 9: Model depicting probable binding sites of DISC1-44mer and FRATtide to GSK3b.  
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the region of DISC1-44mer necessary for binding (15-mer) is distinct from the region necessary 
for inhibition. It is yet unknown if the inhibitory effect of the DISC1-44mer peptide resides in the 
N-terminal end between amino acids 195-211, the C-terminal end between amino acids 224-238, 
or some combination of the regions collectively. Therefore, the model depicted in Figure 5-9 
represents a variety of possible scenarios (A-C) whereby FRATtide binding blocks either the N 
terminus, C-terminus or both termini of the DISC1-44mer without interfering with the middle 15-
mer segment known to be necessary for binding. Scenarios A-C assume that the N- and C-terminal 
regions are flexible or contain a hinge section. This is a basic model which suggests how the two 
peptides might be able to bind simultaneously and create an outcome that has FRATtide physically 
blocking DISC1-44mers ability to inhibit GSK3b.  
Scenario D depicted in Figure 5-9 illustrates a possible situation where FRATtide binding 
causes conformational changes in GSK3b in such a way that prevents DISC1-44mer from forming 
inhibitory interactions with GSK3β. The crystal structure on the right shows GSK3b alone (blue) 
superimposed on GSK3b bound to FRATtide (yellow). The superimposed structure shows four 
distinct regions where the FRATtide bound structure differs from the GSK3b alone structure (dark 
green/dark blue). These regions include residues 118-128 (1), residues 87-93 (2), residues 62-67 
(3) and residues 261-276 (4). With FRATtide bound to GSK3b, region 1 is pushed along the XZ 
plane and turned into the Z axis, region 2 is shifted backward in three-dimensional space in the YZ 
plane, region 3 is shifted forwards in the ZX plane and region 4, which includes the helix and the 
loop, is moved upwards along the YZ plane towards the N-terminal β-strand domain of the 
enzyme. Scenario D illustrated in Figure 5-9 supposes that DISC1-44mer interacts with specific 
regions of GSK3β which are no longer in reach or properly exposed when FRATtide is bound. 
This illustration is just one of multiple ways that DISC1-44mer interaction with GSK3b could be 
altered with the added binding of FRATtide. It is possible that DISC1-44mer is only interacting 
with one of these four regions or any combination of these regions. Region 2 is the C loop of 
GSK3b which is known to be involved in inhibition mechanisms by sitting down on top of 
inhibitors and blocking the active site. Perhaps its subsequent backward shift in response to 
FRATtide binding puts the C loop out of reach for DISC1-44mer eliminating its ability to cause 
inhibition. At this point, it is difficult to make assumptions regarding which of the regions 
described above, if any, are involved with DISC1-44mer binding and inhibition. It is also difficult 
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to determine if DISC1-44mer is physically blocked from inhibition (Figure 5-9 / A-C) or deterred 
by the shifting of GSK3b surface residues (Figure 5-9 / D). However, it is reasonably likely that 
DISC1-44mer and FRATtide are interacting with GSK3b in one of the models depicted in Figure 
5-9. One way to confirm this model includes extended mutagenesis studies. Each of the regions 
described above (1-4) could be mutated individually or in select combinations in separate 
constructs by replacing the amino acids in that region with alanine residues. The new mutated 
constructs would need to be subjected to enzyme activity studies both in the presence and absence 
of DISC1-44mer. Each mutated construct would need to retain full enzyme activity on its own 
before incubation with DISC1-44mer to ensure that the introduced mutations did not interfere with 
the enzymes native function. If DISC1-44mer fails to inhibit any of the mutated constructs it would 
lend evidence to the role that particular region plays in the DISC1-44mer-GSK3β inhibition 
interaction. 
It is essential to consider the SPR data and ADP-GLO data together when attempting to 
develop a model as the SPR sequential binding data and the ADP-GLO kinetic data on their own 
could be interpreted to support different conclusions. The novelty of this combined model is that 
it lends evidence to the likelihood that DISC1-44mer is acting in a non-competitive allosteric 
fashion. Experiments conducted by our collaborators showed that DISC1-44mer acts as an 
inhibitor which is non-competitive for ATP binding. One potential question raised by the model is 
the possibility that DISC1-44mer binding or inhibition might be reversed or negated after the 
addition of FRATtide. This possibility is drawn from the experiments of FRATtide and DISC1-
44mer incubated together with full enzyme activity. For example, if DISC1-44mer is bound to 
GSK3b causing inhibition, FRATtide (with a separate binding site) could be introduced, and its 
binding would shift regions of GSK3b interacting with DISC1-44mer potentially ceasing the 
inhibitory effect. The data from this thesis does not serve to answer this particular query but poses 
it as a potential question for future experiments. To determine if DISC1-44mer inhibition is 
reversible double titration enzyme assay with DISC1-44mer and FRATtide could be conducted. If 
FRATtide was able to reverse DISC1-44mer inhibition the resulting graph would show an increase 
in GSK3b activity with increasing FRATtide concentration. The prospect that FRATtide can 
hinder DISC1-44mers inhibition creates a scenario where enzyme activity could potentially be 
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more strictly controlled or finetuned. In this case, varying concentrations or doses of FRATtide 
and DISC1-44mer could allow for a type of enzyme activity switch.  
5.3.2 Other Possible Explanations 
 Other possible explanations could serve to describe the observed data. One potential scenario 
is that DISC1-44mer and FRATtide are binding to each other (Figure 5-10 / A). It could be possible 
that the exposed surface residues of DISC1-44mer, or the regions of the peptide not directly 
interacting with GSK3β, are a complementary match for the binding residues on FRATtide.  It 
would follow that what is being observed in the SPR sequential binding data (Figure 5-5) is 
FRATtide associating and dissociating from DISC1-44mer instead of from GSK3b itself. In regard  
 
Figure 5- 10: Model to represent the other explanations that could apply to the data.  
Scenario A shows FRATtide binding to DISC1-44mer directly instead of binding to GSK3b. Scenario B depicts 
FRATtide, and DISC1-44mer sharing a binding site but FRATtide associates and dissociates with GSK3b at a rate 
too fast thus not allowing DISC1-44mer the opportunity to bind. Scenario C depicts DISC1-44mer being ejected by 
FRATtide from a shared binding site.  
to the results observed in the ADP-GLO studies, it could be theorized that FRATtide has higher 
affinity for DISC1-44mer than GSK3β and as such FRATtide is sequestering DISC1-44mer away 
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from the enzyme. In this case the full enzyme activity is explained by the lack of any peptide 
binding (Figure 5-8). Out of the three possible scenarios proposed in Figure 5-10 this is the most 
probable. One assay which could potentially help determine if Scenario A (Figure 5-10) is 
occurring would be to produce a His-tagged DISC1-44mer fragment and capture it onto the 
NiNTA surface of the SPR chip. Once captured, FRATtide would be injected across the chip, and 
the resulting response measured. If FRATtide showed any affinity for the DISC1-44mer fragment 
without the presence of GSK3b, then an association curve would  be produced. However, if there 
were no association response, then it would be highly unlikely that Scenario A (Figure 5-10) would 
be an appropriate explanation of the observations. Alternatively, a sample of FRATtide and 
DISC1-44mer could be run on a native gel to determine if the peptides were associating in solution. 
Of course, it could still be a possibility that FRATtide only binds specifically to DISC1-44mer 
while it is bound to GSK3b in which case a native gel of a sample containing GSK3β, FRATtide 
and DISC1-44mer would address this possibility more accurately.  
It could also be argued that FRATtide and DISC1-44mer share a binding site, but since 
FRATtide has a faster association rate for GSK3b than DISC1-44mer (2.4e4 M-1s-1 for FRATtide 
compared to 2.49e4 M-1s-for DISC1-44mer), its non-inhibitory effect is the one predominantly seen 
in the activity assay (Figure 5-8). This theory assumes that since FRATtide has a faster association 
rate, it will bind GSK3b more quickly than DISC1-44mer (Figure 5-10 / B) thereby monopolizing 
the shared binding site.  In this suggested scenario, FRATtide would associate then dissociate then 
re-associate with GSK3b thereby continually occupying the binding site and preventing DISC1-
44mer the opportunity to bind. While this model is plausible and accounts for the non-inhibition 
seen in the ADP-GLO studies, it does not account for the observations recorded by the SPR data. 
For example, if FRATtide were monopolizing a shared binding site the addition of FRATtide after 
DISC1-44mer saturation would not have had such a clear response (Figure 5-4 and Figure 5-5). 
Not only was the response obvious, but it was characteristic in shape, size, and kinetics to 
FRATtide’s standard response to GSK3b alone without the presence of DISC1-44mer. Given the 
lack of support from the SPR data, Scenario B in Figure 5-10 is also possible but not probable.  
A third possibility that could serve to explain the data presented in this chapter is that 
FRATtide is ejecting or replacing bound DISC1-44mer peptide (Figure 5-10 / C) in a competitive 
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fashion. This scenario explains the enzyme activity (ADP-GLO) data as it suggests that any 
GSK3b enzymes inhibited by DISC1-44mer would be freed from this inhibition when FRATtide 
replaced the DISC1-44mer peptide. However, Scenario C (Figure 5-10) is not well supported by 
the SPR data. If FRATtide were actually ejecting DISC1-44mer from a shared binding site, the 
injection of FRATtide would cause a decrease in overall mass on the surface of the NiNTA chip, 
and the response curve would show a decline (Figure 5-4). This is especially true considering 
DISC1-44mer is larger than FRATtide and as such the mass being lost would be higher than the 
mass gained. Similar to Scenarios B (Figure 5-10), Scenario C is also possible but not probable as 
it is only supported by the ADP-GLO data and not the SPR data.  Additional work to further 
address the possibility of Scenario C could include a three-tier version of the sequential SPR 
experiment. This experiment would occur similarly to the original sequential binding (Figure 5-5) 
except immediately after FRATtide injection and dissociation, DISC1-44mer would be injected a 
second time. If FRATtide was actively acting to eject DISC1-44mer then the binding spot would 
be open and available after FRATtide dissociation and a clear response would be observed for the 
second DISC1-44mer injection. This three-tire sequential SPR experiment would clearly indicate 
if FRATtide is acting in a manner which dislodges or removes DISC1-44mer lending more 
evidence to the theory that the two peptides share the same binding site.  
5.3.3 Final Determination of Binding Sites 
 As described above, mutagenesis studies would be helpful in narrowing down the final 
determination of binding sites. The first step would include designing a construct with one of the 
four regions in Figure 5-9/D mutated by replacing the amino acid residues with alanine residues. 
The largest region indicated in Figure 5-9/D is 15 amino acid residues while the smallest region is 
5 amino acid residues. It would be sensible to use site directed mutagenesis to mutate the entirety 
of each of the regions to alanine residues. Site directed mutagenesis works by denaturing the whole 
plasmid, annealing a primer containing the desired mutation and extending. The original/parental 
strand is methylated and thus digested using the enzyme, Dpn1. The nicked DNA is then ligated 
and transformed into competent cells. In the event that none of the four regions mutated alone 
negate DISC1-44mer inhibition then mutation constructs can be designed with different 
combinations of the four regions mutated at the same time. This process can continue until a region, 
or combination of regions, that prevents DISC1-44mer inhibition is identified. Once the broad 
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region is known, smaller segments of mutations within those regions can be done to further narrow 
down the specific residues necessary for DISC1-44mer inhibition. This type of mutagenesis 
experiment relies on enzyme activity assays and as such, controls must be set to ensure that the 
induced mutations on their own do not cause the protein to fold improperly or otherwise be 
inactive. If mutagenesis is unable to produce active mutated enzymes or otherwise unable to 
identify DISC1-44mer binding regions, an alternative way to determine what is happening 
involves crystallography studies. Crystallography studies on GSK3b with DISC1-44mer, GSK3b 
with FRATtide and GSK3b with both DISC1-44mer and FRATtide together would be most 
optimal. Solving of these three structure complexes would allow for definitive determination of 
binding sites. It is the most accurate way to compare and contrast binding patterns and would 
ultimately determine if the two peptides compete for binding or have small overlapping binding 
regions. The hurdles towards obtaining a crystal structure thus far include the yield and purity of 
the GSK3b product which was thoroughly addressed in Chapters 3 and 4.  
 In summary, the data most accurately reflects the model outlined in Figure 5-9 whereby 
DISC1-44mer and FRATtide have binding sites that are close to one another and overlap in a 
region of DISC1-44mer responsible for GSK3b inhibition or that FRATtide binding shifts the 
surface residues required for DISC1-44mer inhibition to occur. This model is supported by both 
the SPR data and the enzyme activity (ADP-GLO) data. In order to confirm this model, a crystal 
structure or mutagenesis studies would be necessary. The additional assays suggested in the section 
proposed to address the other possible scenarios would help lend evidence to prove or disprove 
other possible explanations thereby strengthening the most likely model.  
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6.0 Conclusions & Future Work  
More investigation into the observed phenomenon of FRATtide’s ability to restrict DISC1-
44mer’s inhibition of GSK3β is necessary to draw any concrete conclusions regarding what is 
occurring at the molecular level. However, the data from the SPR studies married with the data 
from the ADP-GLO studies strongly suggest that DISC1-44mer and FRATtide appear to have 
mostly different binding sites. It remains possible that the peptide binding sites may overlap in the 
regions that obstruct DISC1-44mer inhibition without interfering with DISC1-44mer binding. The 
data indicate that both peptides are binding simultaneously and in a manner that does not allow for 
DISC1-44mer to cause inhibition. The data can be interpreted to mean that either small fractions 
of the binding sites overlap (Figure 5-8 / Scenario A, B or C) or that in order to cause inhibition 
DISC1-44mer needs to interact with at least one of the regions of GSK3b that becomes shifted as 
a result of FRATtide binding (Figure 5-8 / Scenario D). This conclusion is supported by the SPR 
data which exhibited FRATtide’s ability to bind GSK3b after DISC1-44mer was already in place. 
Although this sequential binding data does not address the kinetic ability of the enzyme at this 
point, it does indicate that the binding of DISC1-44mer does not interfere with the binding of 
FRATtide. The overall conclusion is also supported by the ADP-GLO results which revealed that 
GSK3b activity in the presence of DISC1-44mer is inhibited compared to the full GSK3b activity 
observed in the presence of FRATtide. This simple observation alone is minor evidence that the 
peptides probably do not share a common inhibition strategy. Finally, the overall conclusion is 
supported by the ADP-GLO studies which show normal GSK3b activity towards GSP2 in the 
presence of both peptides. Both of the proposed models consider the ability of the peptides to bind 
separately but simultaneously while allowing for differing outcomes in enzyme activity. The thesis 
elaborated the original hypothesis that DISC1-44mer and FRATtide compete for the same binding 
site on GSK3b by suggesting instead that the peptides may likely contain binding sites that 
partially overlap. Further investigations involving mutagenesis or structural studies need to be 
completed in order to confirm the suggestions posed by this work. 
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This project is a small subset of a large puzzle involving DISC1’s interaction with GSK3b 
and how that interaction causes inhibition in a seemingly specific and targeted manner. The work 
as a whole is impactful to the scientific community as it provides a baseline interaction that can be 
targeted for drug therapy in the potential treatment of mental health disorders. Suggestions for 
experiments to improve each objective were described in detail within the discussion section of 
each chapter. The first two objectives of overexpression and purification have been brought to the 
point of functionality but would benefit from further optimization so that their execution can be 
done in a more streamlined fashion with a higher overall yield of a protein product containing 
fewer contaminants. The third objective of enzyme studies could benefit from additional SPR and 
ADP-GLO studies which may help eliminate some of the possible scenarios outlined in Figure 5-
10. Future work for this project as a whole should mainly focus on enzymatic, mutagenic and 
crystallographic studies of GSK3b complexed with DISC1-44mer to identify where the peptide 
binds and what, if any, structural changes occur which may cause enzyme inhibition. Furthermore, 
future work should include crystallographic studies of GSK3b complexed with FRATtide and 
DISC1-44mer together to visualize the binding locations of both peptides. Crystallization of this 
complex will allow an accurate representation to compliment the kinetic data provided in this 
thesis regarding FRATtide’s apparent ability to obstruct DISC1-44mers inhibitory effect.  
The potential of confirming DISC1-44mers binding location is an essential piece of 
knowledge both for better understanding the activity of GSK3b's binding partners and for 
identifying what factors of DISC1 binding causes its inhibition to be limited towards specific 
substrates. The potential for confirming FRATtide's ability to obstruct DISC1-44mer’s inhibition 
is valuable to the niche as well because it would provide a greater understanding of DISC1-44mer 
inhibition and add potential avenues for inhibition manipulation. Furthermore, it would also be 
useful to identify the scope of specificity for DISC1-44mer inhibition via GSK3b. Identifying 
which GSK3b substrates are affected as a result of DISC1-44mer inhibition could broaden the 
scope of the utility for DISC1-44mer as a potential drug target and help increase the knowledge 
base surrounding DISC1 and the pathways it is involved in.  
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Appendix A 
 
Total Reagent List 
Acrylamide (Fisher # 01065-500) 
Ampicillin (VWR # CA97061-442) 
APS (Sigma #A3678-100G) 
ATP (Thermo Scientific # FERR0441) 
B-Per Bacterial Extraction (VWR #CAPI90084) 
Bacto-Agar (Anachemia # 02116-300) 
Bacto-Tryptone (Fisher # BP1421-2) 
EDTA (Fisher # PR-V4231) 
Glycerol (Fisher # BP2291) 
HEPES (Fisher # BP3101) 
Imidazole (Fisher # BP30550) 
KH2PO4 (Fluka # 60220) 
K2HPO4 ( Fisher BP363-1) 
Magnesium Chloride (VWR # W1917603
 95 
NiSO4 (Sigma-Aldrich # 7786-81-4) 
Pierce Protease Inibitor (Thermo Fisher# 88666) 
Precision Plus Protein Unstained Standard (Biorad # 161-0363) 
Sodium Chloride (VWR # CA71008-564) 
Sodium Hydroxide (Alfa Aesar # AAA1603736) 
 
TCEP HCl (Fisher-Pierce # PI20491) 
TEMED (Sigma # T9281-100ML) 
Tris Base (Fisher # BP1521) 
Tryptone (Fisher # BP14212) 
Tween 20 (VWR # CA97062-332) 
Yeast Extract (Fisher #BP14222) 
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Appendix B 
 
Western Blot Methods 
 Protein samples were run on a 12% SDS-PAGE gel at 120 V for 90 mins. A n 
Immobilon-FL pore size 0.45 μm membrane (Millipore Cat# IPFL00010) was activated with 
methanol for 30 sec, rinsed with water and then equilibrated with transfer buffer (25 mM Tris, 
192 mM glycine, 20% methanol, pH 8.3) along with the sponge, gel and blotting paper. The 
membrane was placed in-between the blotting paper and the sponges, then assemble into the 
western blot apparatus. The transfer was run at 350 mAmp for 60 min. Once the transfer was 
complete the membrane was rinsed with 1X PBST (3.2 mM Na2HPO4, 1.3 mM KCl, 135 mM 
NaCl, 0.05% Tween 20, pH 7.4) then placed in blocking solution (1X PBST + 5% dry milk 
powder) for 1 hour. Once the membrane was sufficiently incubated in blocking solution it was 
rinsed with PBST and incubated with the primary antibody (Anti-GSK3β at a dilution of 1:6000 
in blocking solution) overnight at 4°C. Following overnight incubation, the membrane was 
washed with PBST and incubated with the secondary antibody (Anti-mouse dylight 680 at a 
dilution of 1:10000 in blocking solution) at room temperature for 1 hour. Following the 
secondary antibody incubation, the membrane was washed with PBST and protein bands were 
detected using a gel imager system.  
